BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020;396:345-60. [PMID: 32738956 DOI: 10.1016/S0140-6736(20)31286-1] [Cited by in Crossref: 357] [Cited by in F6Publishing: 386] [Article Influence: 119.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang Y, Li M, Su Y, Du Y, Wu X, Chen X, Song Y, Lai L, Cheng H. Integrated transcriptomic and metabolomic analyses of DNCB-induced atopic dermatitis in mice. Life Sci 2023;:121474. [PMID: 36746357 DOI: 10.1016/j.lfs.2023.121474] [Reference Citation Analysis]
2 Yélamos O, Andersen D, Pont M, Iglesias P, Potrony M, Domínguez M, Herrero A, Alejo B, Mateu J, Røpke M, Danneskiold-Samsøe NB, Malvehy J, Guy RH, Brix S, Puig S. Development and validation of a minimally invasive and image-guided tape stripping method to sample atopic skin in children. Clin Exp Dermatol 2023;48:80-8. [PMID: 36730521 DOI: 10.1093/ced/llac040] [Reference Citation Analysis]
3 Yang N, Shao H, Deng J, Yang Y, Tang Z, Wu G, Liu Y. Dictamnine ameliorates chronic itch in DNFB-induced atopic dermatitis mice via inhibiting MrgprA3. Biochem Pharmacol 2023;208:115368. [PMID: 36493846 DOI: 10.1016/j.bcp.2022.115368] [Reference Citation Analysis]
4 El Achkar Mello ME, Simoni AG, Rupp ML, de Azevedo Simões PWT, de Souza Pires MM. Quality of life of pediatric patients with atopic dermatitis and their caregivers. Arch Dermatol Res 2023. [PMID: 36723680 DOI: 10.1007/s00403-023-02544-2] [Reference Citation Analysis]
5 Ragamin A, van Halewijn K, Pasmans S, Bindels P. Constitutioneel eczeem: soms complex, maar goed te behandelen. Huisarts Wet 2023;66:30-34. [DOI: 10.1007/s12445-022-2141-3] [Reference Citation Analysis]
6 Vaher H, Kingo K, Kolberg P, Pook M, Raam L, Laanesoo A, Remm A, Tenson T, Alasoo K, Mrowietz U, Weidinger S, Kingo K, Rebane A. Skin colonization with S. aureus can lead to increased NLRP1 inflammasome activation in patients with atopic dermatitis. J Invest Dermatol 2023:S0022-202X(23)00066-0. [PMID: 36736455 DOI: 10.1016/j.jid.2023.01.013] [Reference Citation Analysis]
7 Tan T, Xiao D, Li Q, Zhong C, Hu W, Guo J, Chen X, Zhang H, Lin L, Yang S, Xiong G, Yang H, Yang X, Hao L, Yang N. Maternal yogurt consumption during pregnancy and infantile eczema: a prospective cohort study. Food Funct 2023. [PMID: 36723007 DOI: 10.1039/d2fo02064e] [Reference Citation Analysis]
8 Joshi AA, Vocanson M, Nicolas J, Wolf P, Patra V. Microbial derived antimicrobial peptides as potential therapeutics in atopic dermatitis. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1125635] [Reference Citation Analysis]
9 Weisshaar E, Bentz P, Apfelbacher C, Haufe E, Heinrich L, Heratizadeh A, Abraham S, Harder I, Kleinheinz A, Wollenberg A, Schäkel K, Wiemers F, Ertner J, Augustin M, Wildberger J, Von Kiedrowski R, Worm M, Zink A, Effendy I, Asmussen A, Pawlak M, Sticherling M, Hilgers M, Handrick C, Quist S, Schwarz B, Bell M, Staubach-Renz P, Hong-Weldemann SH, Homey B, Brücher JJ, Weidinger S, Werfel T, Schmitt J; TREATgermany study group. Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany. Acta Derm Venereol 2023;103:adv00854. [PMID: 36688701 DOI: 10.2340/actadv.v103.4426] [Reference Citation Analysis]
10 Wu P, Li C, Chang Y, Chen C, Wu C, Ma S. Management of Atopic Dermatitis During the COVID-19 Pandemic: Key Questions and Review of the Current Evidence. Dermatitis® 2023. [DOI: 10.1089/derm.2022.29019.pwu] [Reference Citation Analysis]
11 Guo M, Su J, Zheng S, Chen B. Objective Sleep in Atopic Dermatitis: A Meta-Analysis. Dermatitis® 2023. [DOI: 10.1089/derm.2022.29005.mgu] [Reference Citation Analysis]
12 Simpson EL, Gooderham M, Wollenberg A, Weidinger S, Armstrong A, Soung J, Ferrucci S, Lima RG, Witte MM, Xu W, ElMaraghy H, Natalie CR, Pierce E, Blauvelt A; ADhere Investigators. Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere). JAMA Dermatol 2023. [PMID: 36630140 DOI: 10.1001/jamadermatol.2022.5534] [Reference Citation Analysis]
13 Teixeira C, Garcia MJ, Freitas A, Silva H. Impact of Atopic Dermatitis on the Mental Health of Adolescents—Literature Review. The II International Meeting on Literacy and Positive Mental Health 2023. [DOI: 10.3390/msf2022016008] [Reference Citation Analysis]
14 Hollestein LM, Ye MYF, Ang KL, Forbes H, Mansfield KE, Abuabara K, Smeeth L, Langan SM. The association between atopic eczema and lymphopenia: Results from a UK cohort study with replication in US survey data. J Eur Acad Dermatol Venereol 2023. [PMID: 36606535 DOI: 10.1111/jdv.18841] [Reference Citation Analysis]
15 Townsend EC, Kalan LR. The dynamic balance of the skin microbiome across the lifespan. Biochem Soc Trans 2023:BST20220216. [PMID: 36606709 DOI: 10.1042/BST20220216] [Reference Citation Analysis]
16 Thyssen JP, Halling AS, Schmid-Grendelmeier P, Guttman-Yassky E, Silverberg JI. Comorbidities of atopic dermatitis-what does the evidence say? J Allergy Clin Immunol 2023:S0091-6749(22)01653-0. [PMID: 36621338 DOI: 10.1016/j.jaci.2022.12.002] [Reference Citation Analysis]
17 Liu W, Xu R, Wang F. Recent Advances of Basophils in Pruritic Skin Diseases. J Invest Dermatol 2023:S0022-202X(22)02889-5. [PMID: 36608999 DOI: 10.1016/j.jid.2022.12.005] [Reference Citation Analysis]
18 Keskitalo PL, Jokelainen J, Tasanen K, Sinikumpu SP, Huilaja L. Juvenile idiopathic arthritis in children and adolescents with atopic dermatitis: A Finnish nationwide registry study. J Am Acad Dermatol 2023:S0190-9622(22)03316-3. [PMID: 36604230 DOI: 10.1016/j.jaad.2022.12.025] [Reference Citation Analysis]
19 Makowska K, Nowaczyk J, Blicharz L, Waśkiel-Burnat A, Czuwara J, Olszewska M, Rudnicka L. Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments. Int J Mol Sci 2023;24. [PMID: 36614224 DOI: 10.3390/ijms24010781] [Reference Citation Analysis]
20 Baloh CH, Mathias RA. Recent progress in the genetic and epigenetic underpinnings of atopy. J Allergy Clin Immunol 2023;151:60-9. [PMID: 36608983 DOI: 10.1016/j.jaci.2022.10.027] [Reference Citation Analysis]
21 Bosma AL, Musters AH, Bloem M, Gerbens LAA, Middelkamp-Hup MA, Haufe E, Schmitt J, Barbarot S, Seneschal J, Staumont-Sallé D, Johansson EK, Bradley M, von Kobyletzki LB, Vittrup I, Frier Ruge I, Thyssen JP, Vestergaard C, de Vega M, García-Doval I, Chiricozzi A, Stingeni L, Calzavara-Pinton P, Ardern-Jones MR, Reynolds NJ, Flohr C, Spuls PI. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce. J Eur Acad Dermatol Venereol 2022. [PMID: 36018221 DOI: 10.1111/jdv.18566] [Reference Citation Analysis]
22 Blauvelt A, Kircik L, Papp KA, Simpson EL, Silverberg JI, Kim BS, Kwatra SG, Kuligowski ME, Venturanza ME, Wei S, Szepietowski JC. Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2022. [PMID: 36066323 DOI: 10.1111/jdv.18571] [Reference Citation Analysis]
23 Koszorú K, Hajdu K, Brodszky V, Bató A, Gergely LH, Kovács A, Beretzky Z, Sárdy M, Szegedi A, Rencz F. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis. Eur J Health Econ 2023;24:139-52. [PMID: 35412162 DOI: 10.1007/s10198-022-01460-y] [Reference Citation Analysis]
24 Weidinger J, Loh R, Brand R, Salter S, Vale S, Said M, Weston S. A Paediatric Eczema Shared Care Model. Worldwide Successful Pediatric Nurse-Led Models of Care 2023. [DOI: 10.1007/978-3-031-22152-1_14] [Reference Citation Analysis]
25 Iturriaga C, Bustos MF, Le Roy C, Rodríguez R, Cifuentes L, Silva-Valenzuela S, Vera-Kellet C, Cristi F, Pérez-Mateluna G, Cabalín C, Hoyos-Bachiloglu R, Camargo CA Jr, Borzutzky A. Association between obesity and atopic dermatitis in children: A case-control study in a high obesity prevalence population. Pediatr Dermatol 2023;40:64-8. [PMID: 36047809 DOI: 10.1111/pde.15110] [Reference Citation Analysis]
26 Worm M, Glatzel V, Baumgart S, Mei HE, Sörensen T, Grützkau A, Heine G. Immune cell profiling reveals natural killer and T cell subpopulations to be associated with atopic dermatitis severity. Clin Exp Allergy 2023;53:105-8. [PMID: 36102492 DOI: 10.1111/cea.14228] [Reference Citation Analysis]
27 Cui H, Mu Z. Prenatal Maternal Risk Factors Contributing to Atopic Dermatitis: A Systematic Review and Meta-Analysis of Cohort Studies. Ann Dermatol 2023;35:11. [DOI: 10.5021/ad.21.268] [Reference Citation Analysis]
28 Shao Y, Zhu Y, Xiao Z, Shen Y, Dai B, Tang H, Wang D. RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching. Exp Dermatol 2023;32:30-40. [PMID: 36134503 DOI: 10.1111/exd.14678] [Reference Citation Analysis]
29 Guttman-Yassky E, Thyssen JP, Silverberg JI, Papp KA, Paller AS, Weidinger S, Chih-Ho Hong H, Hendrickson B, Dilley D, Tenorio AR, Ladizinski B, Chu AD, Liu J, Irvine AD. Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies. J Allergy Clin Immunol 2023;151:172-81. [PMID: 36195170 DOI: 10.1016/j.jaci.2022.09.023] [Reference Citation Analysis]
30 Färdig M, Gudmundsdóttir HK, Hoyer A, Bains KES, Almqvist C, Monceyron Jonassen C, Rehbinder EM, Skjerven HO, Staff AC, Vettukattil R, Söderhäll C, Carlsen KCL, Nordlund B. Skin Barrier Function and Infant Tidal Flow-Volume Loops-A Population-Based Observational Study. Children (Basel) 2022;10. [PMID: 36670639 DOI: 10.3390/children10010088] [Reference Citation Analysis]
31 Ma X, Liu B, Fan L, Liu Y, Zhao Y, Ren T, Li Y, Li Y. Native and engineered exosomes for inflammatory disease. Nano Res 2022;:1-16. [PMID: 36591564 DOI: 10.1007/s12274-022-5275-5] [Reference Citation Analysis]
32 Pontone M, Giovannini M, Filippeschi C, Oranges T, Pedaci FA, Mori F, Barni S, Barbati F, Consonni F, Indolfi G, Lodi L, Azzari C, Ricci S, Hovnanian A. Biological treatments for pediatric Netherton syndrome. Front Pediatr 2022;10:1074243. [PMID: 36619513 DOI: 10.3389/fped.2022.1074243] [Reference Citation Analysis]
33 Halling AS, Rinnov MR, Ruge IF, Gerner T, Ravn NH, Knudgaard MH, Trautner S, Loft N, Skov L, Thomsen SF, Egeberg A, Guttman-Yassky E, Rosted ALL, Petersen T, Jakasa I, Kezic S, Thyssen JP. Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis. J Allergy Clin Immunol 2022:S0091-6749(22)02503-9. [PMID: 36572354 DOI: 10.1016/j.jaci.2022.11.023] [Reference Citation Analysis]
34 Ziyab AH, Holloway JW, Ali YM, Zhang H, Karmaus W. Eczema among adolescents in Kuwait: Prevalence, severity, sleep disturbance, antihistamine use, and risk factors. World Allergy Organ J 2023;16:100731. [PMID: 36601260 DOI: 10.1016/j.waojou.2022.100731] [Reference Citation Analysis]
35 De Simoni E, Rizzetto G, Molinelli E, Lucarini G, Mattioli-Belmonte M, Capodaglio I, Ferretti G, Bacchetti T, Offidani A, Simonetti O. Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review. Life (Basel) 2022;13. [PMID: 36675951 DOI: 10.3390/life13010002] [Reference Citation Analysis]
36 Moennig E, Traidl S. Real-World Experience with Tralokinumab in a Patient with Recalcitrant Atopic Dermatitis: A Case Report. Clin Cosmet Investig Dermatol 2022;15:2825-30. [PMID: 36573170 DOI: 10.2147/CCID.S382424] [Reference Citation Analysis]
37 Lee Y, Oh JH, Li N, Jang HJ, Ahn KS, Oh SR, Lee DH, Chung JH. Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types. Front Immunol 2022;13:1064515. [PMID: 36605189 DOI: 10.3389/fimmu.2022.1064515] [Reference Citation Analysis]
38 Adesanya EI, Matthewman J, Schonmann Y, Hayes JF, Henderson A, Mathur R, Mulick AR, Smith CH, Langan SM, Mansfield KE. Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysis. Br J Dermatol 2022:ljac132. [PMID: 36745557 DOI: 10.1093/bjd/ljac132] [Reference Citation Analysis]
39 Sun PY, Li HG, Xu QY, Zhang Z, Chen JW, Shen YH, Qi X, Lu JF, Tan YD, Wang XX, Li CX, Yang MY, Ma YZ, Lu Y, Xu TL, Shen JW, Li WG, Guo YF, Yao ZR. Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons. Br J Pharmacol 2022. [PMID: 36521846 DOI: 10.1111/bph.16012] [Reference Citation Analysis]
40 Silverberg JI, Simpson EL, Thyssen JP, Werfel T, Cardillo TE, Colvin S, Pierce E, Chen YF, Chen S, Eichenfield L. Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7. J Eur Acad Dermatol Venereol 2022. [PMID: 36514996 DOI: 10.1111/jdv.18816] [Reference Citation Analysis]
41 Schäbitz A, Hillig C, Mubarak M, Jargosch M, Farnoud A, Scala E, Kurzen N, Pilz AC, Bhalla N, Thomas J, Stahle M, Biedermann T, Schmidt-Weber CB, Theis F, Garzorz-Stark N, Eyerich K, Menden MP, Eyerich S. Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases. Nat Commun 2022;13:7729. [PMID: 36513651 DOI: 10.1038/s41467-022-35319-w] [Reference Citation Analysis]
42 Yue W, Cheng D, Sun Z, Shen Y, Wang S, Liu X, Pei X, Deng S, Pan H, Liao Z, Li W, Yao X, Liang Y, Song Z, Yao Z, Zhang H, Guo Y. Validation of diagnostic criteria for atopic dermatitis and proposal of novel diagnostic criteria for adult and elderly Chinese populations: a multicentre, prospective, clinical setting-based study. Br J Dermatol 2022:ljac097. [PMID: 36637142 DOI: 10.1093/bjd/ljac097] [Reference Citation Analysis]
43 Jiang P, Wu Y, Liu L, Zhang L, Song Z. Combined application of dinitrofluorobenzene and ovalbumin induced AD-like dermatitis with an increase in helper T-cell cytokines and a prolonged Th2 response. BMC Immunol 2022;23:60. [PMID: 36476273 DOI: 10.1186/s12865-022-00531-2] [Reference Citation Analysis]
44 Beck LA, Bieber T, Weidinger S, Tauber M, Saeki H, Irvine AD, Eichenfield LF, Werfel T, Arlert P, Jiang L, Røpke M, Paller AS. Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial. J Am Acad Dermatol 2022:S0190-9622(22)03150-4. [PMID: 36473633 DOI: 10.1016/j.jaad.2022.11.047] [Reference Citation Analysis]
45 Moniaga CS, Tominaga M, Takamori K. An Altered Skin and Gut Microbiota Are Involved in the Modulation of Itch in Atopic Dermatitis. Cells 2022;11. [PMID: 36497188 DOI: 10.3390/cells11233930] [Reference Citation Analysis]
46 Blicharz L, Żochowski M, Szymanek-Majchrzak K, Czuwara J, Goldust M, Skowroński K, Młynarczyk G, Olszewska M, Samochocki Z, Rudnicka L. Enterotoxin Gene Cluster and selX Are Associated with Atopic Dermatitis Severity-A Cross-Sectional Molecular Study of Staphylococcus aureus Superantigens. Cells 2022;11. [PMID: 36497178 DOI: 10.3390/cells11233921] [Reference Citation Analysis]
47 Kim H. Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01421-2] [Reference Citation Analysis]
48 Zhao Y, Wu L, Lu Q, Gao X, Zhu X, Yao X, Li L, Li W, Ding Y, Song Z, Liu L, Dang N, Zhang C, Liu X, Gu J, Wang J, Geng S, Liu Q, Guo Y, Dong L, Li S, Xu C, O’malley JT, Laws E, Amin N, Bansal A, Wang M, Zhang J. Laboratory Safety of Dupilumab, and Its Effect on Inflammatory Biomarkers, in Chinese Adults With Moderate-to-Severe Atopic Dermatitis: An Analysis of a Randomized, Double-Blind Phase III Study. International Journal of Dermatology and Venereology 2022;5:218-225. [DOI: 10.1097/jd9.0000000000000264] [Reference Citation Analysis]
49 Gomułka K, Wójcik E, Szepietowski JC. Serum Levels of Eosinophil-Derived Neurotoxin, Platelet-Activating Factor and Vascular Endothelial Growth Factor in Adult Patients with Atopic Dermatitis-A Pilot Study. Biomedicines 2022;10. [PMID: 36551865 DOI: 10.3390/biomedicines10123109] [Reference Citation Analysis]
50 Yu S, Peng W, Qiu F, Zhang G. Research progress of astragaloside IV in the treatment of atopic diseases. Biomedicine & Pharmacotherapy 2022;156:113989. [DOI: 10.1016/j.biopha.2022.113989] [Reference Citation Analysis]
51 Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens LAA, Schmitt J, Spuls PI, Thomas KS, Howells L, Williams HC, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative. Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative. JAMA Dermatol 2022;158:1429-35. [PMID: 36223090 DOI: 10.1001/jamadermatol.2022.4211] [Reference Citation Analysis]
52 Kamiya S, Ikegami I, Yanagi M, Takaki H, Kamekura R, Sato T, Kobayashi K, Kamiya T, Kamada Y, Abe T, Inoue KI, Hida T, Uhara H, Ichimiya S. Functional Interplay between IL-9 and Peptide YY Contributes to Chronic Skin Inflammation. J Invest Dermatol 2022;142:3222-3231.e5. [PMID: 35850207 DOI: 10.1016/j.jid.2022.06.021] [Reference Citation Analysis]
53 Son SW, Lee JH, Ahn J, Chang SE, Choi EH, Han TY, Jang YH, Kim HO, Kim MB, Kim YC, Ko HC, Ko JY, Lee SE, Lee YW, Lew BL, Na CH, Park CO, Park CW, Park KY, Park K, Park YL, Roh JY, Seo YJ, Shin MK, Lee S, Cho SH. Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea. Ann Dermatol 2022;34:419-30. [PMID: 36478424 DOI: 10.5021/ad.21.239] [Reference Citation Analysis]
54 Liu L, Song G, Song Z. Intrinsic Atopic Dermatitis and Extrinsic Atopic Dermatitis: Similarities and Differences. CCID 2022;Volume 15:2621-2628. [DOI: 10.2147/ccid.s391360] [Reference Citation Analysis]
55 Elmelid A, Osmancevic A, Gillstedt M, Alsterholm M. Effects of Phototherapy on Free Vitamin D Levels in Ten Patients with Atopic Dermatitis. IJTM 2022;2:586-596. [DOI: 10.3390/ijtm2040044] [Reference Citation Analysis]
56 D'Auria E, Acunzo M, Salvatore S, Grazi R, Agosti M, Vandenplas Y, Zuccotti G. Biotics in atopic diseases: state of the art and future perspectives. Minerva Pediatr (Torino) 2022;74:688-702. [PMID: 36149096 DOI: 10.23736/S2724-5276.22.07010-0] [Reference Citation Analysis]
57 Hua C, Chen S, Cheng H. Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases. Hum Vaccin Immunother 2022;18:2144667. [PMID: 36382475 DOI: 10.1080/21645515.2022.2144667] [Reference Citation Analysis]
58 Xia D, Wang Y, Xiao Y, Li W. Applications of single-cell RNA sequencing in atopic dermatitis and psoriasis. Front Immunol 2022;13:1038744. [PMID: 36505405 DOI: 10.3389/fimmu.2022.1038744] [Reference Citation Analysis]
59 Makris A, Barkas F, Sfikakis PP, Liberopoulos E, Agouridis AP. The Effect of Upadacitinib on Lipid Profile and Cardiovascular Events: A Meta-Analysis of Randomized Controlled Trials. J Clin Med 2022;11. [PMID: 36498468 DOI: 10.3390/jcm11236894] [Reference Citation Analysis]
60 Yu L, Li L. Potential biomarkers of atopic dermatitis. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1028694] [Reference Citation Analysis]
61 Lobefaro F, Gualdi G, Di Nuzzo S, Amerio P. Atopic Dermatitis: Clinical Aspects and Unmet Needs. Biomedicines 2022;10. [PMID: 36428493 DOI: 10.3390/biomedicines10112927] [Reference Citation Analysis]
62 Lytvyn Y, Mufti A, Abduelmula A, Sachdeva M, Maliyar K, Georgakopoulos JR, Yeung J. Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review. Pharmaceutics 2022;14. [PMID: 36432643 DOI: 10.3390/pharmaceutics14112452] [Reference Citation Analysis]
63 Vetrano S, Bouma G, Benschop RJ, Birngruber T, Costanzo A, D’haens GRAM, Frasca L, Hillenbrand R, Iversen L, Johansen C, Kaser A, Koenen HJPM, Noehammer C, Peyrin-biroulet L, Raes J, Ricotti L, Rosenstiel P, Satagopam VP, Schreiber S, Vermeire S, Wollenberg A, Weidinger S, Ziemek D, Danese S, ImmUniverse Consortium. ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1002629] [Reference Citation Analysis]
64 Zeng# Y, Wang# D, Liu Y, Tang Z, Zong X, Li X, Yang S, Lu J. Sodium thiosulfate ameliorates atopic dermatitis symptoms via inhibiting inflammatory infiltration and restoring skin barrier function.. [DOI: 10.21203/rs.3.rs-2231628/v1] [Reference Citation Analysis]
65 Olivry T, Lokianskiene V, Blanco A, Mestre P, Bergvall K, Beco L. A randomised controlled trial testing the rebound‐preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis. Veterinary Dermatology 2022. [DOI: 10.1111/vde.13134] [Reference Citation Analysis]
66 Tukaj S. Circulating heat shock protein 90 (Hsp90) in atopic dermatitis and bullous pemphigoid: is there a link? Cell Stress Chaperones 2022;27:601-2. [PMID: 36161584 DOI: 10.1007/s12192-022-01298-6] [Reference Citation Analysis]
67 Chen Z, Xu Q, Liu Y, Wei Y, He S, Lin W, Wang Y, Li L, Xu Y. Vancomycin-induced gut microbiota dysbiosis aggravates allergic rhinitis in mice by altered short-chain fatty acids. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1002084] [Reference Citation Analysis]
68 Yu B, Zhou L, Zhang X, Hu G, Min H, Qiu Y, Huang T, Wang Y, Zhu M, Yu H. Respiration-Mediated Self-Switched Triboelectric Nanogenerator for Wearable Point-of-Care Prevention and Alarm of Asthma. Nano Energy 2022. [DOI: 10.1016/j.nanoen.2022.108058] [Reference Citation Analysis]
69 Szczepańska M, Blicharz L, Nowaczyk J, Makowska K, Goldust M, Waśkiel-burnat A, Czuwara J, Samochocki Z, Rudnicka L. The Role of the Cutaneous Mycobiome in Atopic Dermatitis. JoF 2022;8:1153. [DOI: 10.3390/jof8111153] [Reference Citation Analysis]
70 Zhou X, Xiao B, Zeng J, Zhou L, Wang X, Zhao S, Li X, Zhang H, Su Y, Zhao Z, Li X. Identification of Cofilin‐1 as a novel biomarker of atopic dermatitis using iTRAQ quantitative proteomics. Clinical Laboratory Analysis 2022. [DOI: 10.1002/jcla.24751] [Reference Citation Analysis]
71 Ilves L, Ottas A, Kaldvee B, Abram K, Soomets U, Zilmer M, Jaks V, Kingo K. Metabolomic Differences between the Skin and Blood Sera of Atopic Dermatitis and Psoriasis. IJMS 2022;23:13001. [DOI: 10.3390/ijms232113001] [Reference Citation Analysis]
72 Bratkovskaya AV, Snarskaya ES. Novel filagrinol-containing emollient. Vestnik dermatologii i venerologii 2022. [DOI: 10.25208/vdv1342] [Reference Citation Analysis]
73 Ivert LU, Svedbom A, Lundqvist M, Wahlgren C, Bradley M, Johansson EK. The Impact of Systemic Treatment of Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort Study. Acta Derm Venereol 2022;102:adv00801. [DOI: 10.2340/actadv.v102.803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Paller AS, Yosipovitch G, Weidinger S, DiBenedetti D, Whalley D, Gadkari A, Guillemin I, Zhang H, Eckert L, Chao J, Bansal A, Chuang CC, Delevry D. Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis. Dermatol Ther (Heidelb) 2022. [PMID: 36269504 DOI: 10.1007/s13555-022-00804-z] [Reference Citation Analysis]
75 Ni X, Xu Y, Wang W, Kong B, Ouyang J, Chen J, Yan M, Wu Y, Chen Q, Wang X, Li H, Gao X, Guo H, Cui L, Chen Z, Shi Y, Zhu R, Li W, Shi T, Wang LF, Huang J, Dong C, Lai Y. IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation. Nat Immunol 2022. [PMID: 36271146 DOI: 10.1038/s41590-022-01339-3] [Reference Citation Analysis]
76 Pat Y, Ogulur I, Yazici D, Mitamura Y, Cevhertas L, Küçükkase OC, Mesisser SS, Akdis M, Nadeau K, Akdis CA. Effect of altered human exposome on the skin and mucosal epithelial barrier integrity. Tissue Barriers 2022;:2133877. [PMID: 36262078 DOI: 10.1080/21688370.2022.2133877] [Reference Citation Analysis]
77 Khan SA, Wu Y, Li AS, Fu XQ, Yu ZL. Network pharmacology and molecular docking-based prediction of active compounds and mechanisms of action of Cnidii Fructus in treating atopic dermatitis. BMC Complement Med Ther 2022;22:275. [PMID: 36261841 DOI: 10.1186/s12906-022-03734-7] [Reference Citation Analysis]
78 Shi L, Liu C, Xiong H, Shi D. Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon? Front Med (Lausanne) 2022;9:1007892. [PMID: 36314037 DOI: 10.3389/fmed.2022.1007892] [Reference Citation Analysis]
79 Jia J, Feng L, Ye S, Ping R, Mo X, Zhang Y, Li X, Chen D. Therapeutic effect of chinese herbal medicine gu-ben-hua-shi (AESS) formula on atopic dermatitis through regulation of yes-associated protein. Front Pharmacol 2022;13:929580. [DOI: 10.3389/fphar.2022.929580] [Reference Citation Analysis]
80 Budu-aggrey A, Kilanowski A, Sobczyk MK, Shringarpure SS, Mitchell R, Reis K, Reigo A, Mägi R, Nelis M, Tanaka N, Brumpton BM, Thomas LF, Sole-navais P, Flatley C, Espuela-ortiz A, Herrera-luis E, Lominchar JV, Bork-jensen J, Marenholz I, Arnau-soler A, Jeong A, Fawcett KA, Baurecht H, Rodriguez E, Alves AC, Kumar A, Sleiman PM, Chang X, Medina-gomez C, Hu C, Xu C, Qi C, El-heis S, Titcombe P, Antoun E, Fadista J, Wang CA, Thiering E, Xiao S, Kress S, Kothalawala DM, Kadalayil L, Duan J, Zhang H, Hoffmann T, Jorgenson E, Choquet H, Risch N, Njølstad P, Andreassen OA, Johansson S, Almqvist C, Gong T, Ullemar V, Karlsson R, Magnusson PK, Szwajda A, Burchard EG, Thyssen JP, Hansen T, Kårhus LL, Dantoft TM, Jeanrenaud AC, Ghauri A, Arnold A, Homuth G, Lau S, Nöthen MM, Hübner N, Imboden M, Visconti A, Falchi M, Bataille V, Hysi P, Ballardini N, Boomsma DI, Hottenga JJ, Müller-nurasyid M, Ahluwalia TS, Stokholm J, Chawes B, Schoos A, Esplugues A, Bustamante M, Raby B, Arshad H, German C, Esko T, Milani LA, Metspalu A, Terao C, Abuabara K, Løset M, Hveem K, Jacobsson B, Pino-yanes M, Strachan DP, Grarup N, Linneberg A, Lee Y, Probst-hensch N, Weidinger S, Jarvelin M, Melén E, Hakonarson H, Irvine AD, Jarvis DL, Nijsten T, Duijts L, Vonk JM, Koppelmann GH, Godfrey KM, Barton SJ, Feenstra B, Pennell CE, Sly PD, Holt PG, Williams KL, Bisgaard H, Bønnelykke K, Curtin J, Simpson A, Murray C, Schikowski T, Bunyavanich S, Weiss ST, Holloway JW, Min J, Brown SJ, Standl M, Paternoster L, 23andMe Research Team. European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation.. [DOI: 10.1101/2022.10.05.22279072] [Reference Citation Analysis]
81 Martínez-fernández S, Batalla A, Suh-oh H, Pousa-martínez M, Casas-fernández L, Flórez Á. Dupilumab en niños y adolescentes con dermatitis atópica: serie de casos y revisión de la literatura. Piel 2022. [DOI: 10.1016/j.piel.2022.07.016] [Reference Citation Analysis]
82 Gao H, Zhang Z, Ma L, Xu Y, Hu Y, Luo X. Photosensitivity is an important cause of refractory facial erythema in atopic dermatitis: A retrospective study of 82 Chinese patients. Photoderm Photoimm Photomed 2022. [DOI: 10.1111/phpp.12836] [Reference Citation Analysis]
83 Labib A, Yosipovitch G. An evaluation of abrocitinib for moderate-to-severe atopic dermatitis. Expert Rev Clin Immunol 2022;:1-12. [PMID: 36173402 DOI: 10.1080/1744666X.2022.2126353] [Reference Citation Analysis]
84 Musters AH, Broderick C, Prieto-Merino D, Chiricozzi A, Damiani G, Peris K, Dhar S, De A, Freeman E, Arents BWM, Burton T, Bosma ALL, Chi CC, Fletcher G, Drucker AM, Kabashima K, de Monchy EF, Panda M, Wall DR, Vestergaard C, Mahé E, Bonzano L, Kattach L, Napolitano M, Ordoñez-Rubiano MF, Haufe E, Patruno C, Irvine AD, Spuls PI, Flohr C. The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry. J Eur Acad Dermatol Venereol 2023;37:365-81. [PMID: 36169355 DOI: 10.1111/jdv.18613] [Reference Citation Analysis]
85 Wang F, Nie H, Shi C. Short-term effects of meteorological factors on childhood atopic dermatitis in Lanzhou, China. Environ Sci Pollut Res Int 2022. [PMID: 36166129 DOI: 10.1007/s11356-022-23250-y] [Reference Citation Analysis]
86 Wang F, Klose CSN, Zhang J. Editorial: Dysregulation of innate immunity in inflammatory skin disorders. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1024791] [Reference Citation Analysis]
87 Pandey R, Jangid A, Vinjamuri RG, Ramaswamy R. Modeling of indirect cell-cell interaction networks mediated by IFNγ/IL-4 cytokine involved in atopic dermatitis. J Theor Biol 2022;:111291. [PMID: 36167121 DOI: 10.1016/j.jtbi.2022.111291] [Reference Citation Analysis]
88 Wu H, Ke X, Huang W, Shi W, Yao S, Duan YY, Tian W, Dong SS, Xue HZ, Guo Y. Multitissue Integrative Analysis Identifies Susceptibility Genes for Atopic Dermatitis. J Invest Dermatol 2022:S0022-202X(22)01940-6. [PMID: 36155055 DOI: 10.1016/j.jid.2022.09.006] [Reference Citation Analysis]
89 Rick JW, Lio P, Atluri S, Hsiao JL, Shi VY. Atopic Dermatitis: A Guide to Transitioning to Janus Kinase Inhibitors. Dermatitis 2022. [PMID: 36125529 DOI: 10.1097/DER.0000000000000950] [Reference Citation Analysis]
90 Lai QWS, Fan Q, Zheng BZ, Chen Y, Dong TT, Tsim KWK. Edible bird’s nest, an Asian health food supplement, possesses anti-inflammatory responses in restoring the symptoms of atopic dermatitis: An analysis of signaling cascades. Front Pharmacol 2022;13:941413. [DOI: 10.3389/fphar.2022.941413] [Reference Citation Analysis]
91 Feng S, Song G, Liu L, Liu W, Liang G, Song Z. Allergen-specific immunotherapy induces monocyte-derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model. J Dermatol 2022. [PMID: 36117445 DOI: 10.1111/1346-8138.16582] [Reference Citation Analysis]
92 Hodara E, Ong PY. The Genetics of Eczema Herpeticum. Clinic Rev Allerg Immunol. [DOI: 10.1007/s12016-022-08953-x] [Reference Citation Analysis]
93 Blauvelt A, Szepietowski JC, Papp K, Simpson EL, Silverberg JI, Kim BS, Kwatra SG, Kuligowski ME, Venturanza ME, Wei S, Kircik L. Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies. J Am Acad Dermatol 2022:S0190-9622(22)02688-3. [PMID: 36113614 DOI: 10.1016/j.jaad.2022.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
94 Preis S, Schmidt L, Tizek L, Schielein M, Lang V, Bleuel R, Duswald A, Sitaru S, Blasini A, Gasteiger C, Merdha L, Kurgyis Z, Kuschel B, Hauenstein E, Sander M, Niedermeier S, Argiriu D, Engel S, Skabytska Y, Silva RL, Hils M, Evers B, Kaesler S, Hufnagel H, Köberle M, Amar Y, Zink A, Biedermann T. Munich atopy prediction study (MAPS): protocol for a prospective birth cohort addressing clinical and molecular risk factors for atopic dermatitis in early childhood. BMJ Open 2022;12:e059256. [PMID: 36691202 DOI: 10.1136/bmjopen-2021-059256] [Reference Citation Analysis]
95 Johansson EK, Brenneche A, Trangbaek D, Stelmaszuk MN, Freilich J, Anderson CD. Treatment Patterns among Patients with Atopic Dermatitis in Secondary Care: A National, Observational, Non-interventional, Retrospective Study in Sweden. Acta Derm Venereol 2022;102:adv00774. [DOI: 10.2340/actadv.v102.1986] [Reference Citation Analysis]
96 Volke A, Toompere K, Laisaar KT, Oona M, Tisler A, Johannson A, Kallavus K, Lang K, Kiisk E, Uusküla A. 12-month prevalence of atopic dermatitis in resource-rich countries: a systematic review and meta-analysis. Sci Rep 2022;12:15125. [PMID: 36068263 DOI: 10.1038/s41598-022-19508-7] [Reference Citation Analysis]
97 Yen FS, Hsu CC, Hu KC, Hung YT, Hsu CY, Wei JC, Hwu CM. Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes. Int J Environ Res Public Health 2022;19. [PMID: 36078769 DOI: 10.3390/ijerph191711045] [Reference Citation Analysis]
98 Saeki H, Ohya Y, Furuta J, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, Tanaka A, Tsunemi Y, Nakahara T, Nagao M, Narita M, Hide M, Fujisawa T, Futamura M, Masuda K, Matsubara T, Murota H, Yamamoto-Hanada K; Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021, The Japanese Society of Allergology, The Japanese Dermatology Association. Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021. Allergol Int 2022:S1323-8930(22)00078-8. [PMID: 36064654 DOI: 10.1016/j.alit.2022.06.009] [Reference Citation Analysis]
99 Yuan H, Sun Y, Tang Y, Zhang Y, Liu S, Liu J, Zhang S, Gao Y, Feng J, Zheng F. Intervention of the Mahuang Lianqiao Chixiaodou decoction on immune imbalance in atopic dermatitis-like model mice. Journal of Traditional Chinese Medical Sciences 2022. [DOI: 10.1016/j.jtcms.2022.09.001] [Reference Citation Analysis]
100 Peng Z, Braig S, Kurz D, Weiss JM, Weidinger S, Brenner H, Rothenbacher D, Genuneit J. Trajectory and determinants of agreement between parental and physicians' reports of childhood atopic dermatitis. Pediatr Allergy Immunol 2022;33:e13855. [PMID: 36156820 DOI: 10.1111/pai.13855] [Reference Citation Analysis]
101 Fiocchi A, Cabana MD, Mennini M. Current Use of Probiotics and Prebiotics in Allergy. J Allergy Clin Immunol Pract 2022;10:2219-42. [PMID: 35792336 DOI: 10.1016/j.jaip.2022.06.038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
102 Tanaka T, Sasaki T, Ikeda K, Liu J, Tenorio AR, Ohya Y. Growth analysis among adolescents with moderate-to-severe atopic dermatitis receiving upadacitinib in combination with topical corticosteroids in Japan: A case study series from a phase 3, randomized, controlled trial (Rising Up). World Allergy Organ J 2022;15:100678. [PMID: 36185549 DOI: 10.1016/j.waojou.2022.100678] [Reference Citation Analysis]
103 Li W, Man XY. Immunotherapy in atopic dermatitis. Immunotherapy 2022. [PMID: 36046941 DOI: 10.2217/imt-2022-0054] [Reference Citation Analysis]
104 Cather J, Young M, DiRuggiero DC, Tofte S, Williams L, Gonzalez T. A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up. Dermatol Ther (Heidelb) 2022. [PMID: 36028787 DOI: 10.1007/s13555-022-00778-y] [Reference Citation Analysis]
105 Xie L, Yang K, Liang Y, Zhu Z, Yuan Z, Du Z. Tremella fuciformis polysaccharides alleviate induced atopic dermatitis in mice by regulating immune response and gut microbiota. Front Pharmacol 2022;13:944801. [DOI: 10.3389/fphar.2022.944801] [Reference Citation Analysis]
106 Chen TL, Lee LL, Huang HK, Chen LY, Loh CH, Chi CC. Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors: A Systematic Review and Meta-analysis. JAMA Dermatol 2022. [PMID: 36001310 DOI: 10.1001/jamadermatol.2022.3516] [Reference Citation Analysis]
107 Saeki H, Ohya Y, Furuta J, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, Tanaka A, Tsunemi Y, Nakahara T, Nagao M, Narita M, Hide M, Fujisawa T, Futamura M, Masuda K, Matsubara T, Murota H, Yamamoto-Hanada K. English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021. J Dermatol 2022. [PMID: 35996152 DOI: 10.1111/1346-8138.16527] [Reference Citation Analysis]
108 Tukaj S, Sitko K. Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases. Biomolecules 2022;12:1153. [PMID: 36009046 DOI: 10.3390/biom12081153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Dębińska A, Danielewicz H, Sozańska B. Genetic Variants in Epidermal Differentiation Complex Genes as Predictive Biomarkers for Atopic Eczema, Allergic Sensitization, and Eczema-Associated Asthma in a 6-Year Follow-Up Case-Control Study in Children. J Clin Med 2022;11:4865. [PMID: 36013110 DOI: 10.3390/jcm11164865] [Reference Citation Analysis]
110 Umar BU, Rahman S, Dutta S, Islam T, Nusrat N, Chowdhury K, Binti Wan Ahmad Fakuradzi WFS, Haque M. Management of Atopic Dermatitis: The Role of Tacrolimus. Cureus 2022. [DOI: 10.7759/cureus.28130] [Reference Citation Analysis]
111 Piazza S, Martinelli G, Magnavacca A, Fumagalli M, Pozzoli C, Terno M, Canilli L, Angarano M, Maranta N, Dell’agli M, Sangiovanni E. Unveiling the Ability of Witch Hazel (Hamamelis virginiana L.) Bark Extract to Impair Keratinocyte Inflammatory Cascade Typical of Atopic Eczema. IJMS 2022;23:9279. [DOI: 10.3390/ijms23169279] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Lv W, Huang J, Li S, Gong X, Sun J, Mao W, Guo S. Portulaca oleracea L. extracts alleviate 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. Front Nutr 2022;9:986943. [DOI: 10.3389/fnut.2022.986943] [Reference Citation Analysis]
113 Gregoriou S, Stefanou G, Kontodimas S, Sfaelos K, Zavali M, Vakirlis E, Kourlaba G. Burden of Atopic Dermatitis in Adults in Greece: Results from a Nationwide Survey. JCM 2022;11:4777. [DOI: 10.3390/jcm11164777] [Reference Citation Analysis]
114 Möckel M, De La Cruz NC, Rübsam M, Wirtz L, Tantcheva-Poor I, Malter W, Zinser M, Bieber T, Knebel-Mörsdorf D. Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon Ex Vivo Infection of Skin from Atopic Dermatitis Patients. J Virol 2022;:e0086422. [PMID: 35969080 DOI: 10.1128/jvi.00864-22] [Reference Citation Analysis]
115 Lee JH, Choi A, Noh Y, Oh IS, Jeon JY, Yoo HJ, Shin JY, Son SW. Real-world treatment patterns for atopic dermatitis in South Korea. Sci Rep 2022;12:13626. [PMID: 35948589 DOI: 10.1038/s41598-022-17222-y] [Reference Citation Analysis]
116 Huang Z, Chu M, Chen X, Wang Z, Jiang L, Ma Y, Wang Y. Th2A cells: The pathogenic players in allergic diseases. Front Immunol 2022;13:916778. [DOI: 10.3389/fimmu.2022.916778] [Reference Citation Analysis]
117 Weimer DS, Demory Beckler M. Underlying Immune Mechanisms Involved in Cow’s Milk-Induced Hypersensitivity Reactions Manifesting as Atopic Dermatitis. Cureus 2022. [DOI: 10.7759/cureus.27604] [Reference Citation Analysis]
118 Gomes TF, Kieselova K, Guiote V, Henrique M, Santiago F. A low level of health literacy is a predictor of corticophobia in atopic dermatitis. Anais Brasileiros de Dermatologia 2022. [DOI: 10.1016/j.abd.2021.11.007] [Reference Citation Analysis]
119 Zeng H, Zhao B, Zhang D, Rui X, Hou X, Chen X, Zhang B, Yuan Y, Deng H, Ge G. Viola yedoensis Makino formula alleviates DNCB-induced atopic dermatitis by activating JAK2/STAT3 signaling pathway and promoting M2 macrophages polarization. Phytomedicine 2022;103:154228. [DOI: 10.1016/j.phymed.2022.154228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Carucci L, Nocerino R, Paparo L, De Filippis F, Coppola S, Giglio V, Cozzolino T, Valentino V, Sequino G, Bedogni G, Russo R, Ercolini D, Berni Canani R. Therapeutic affects elicited by the probiotic Lacticaseibacillusrhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial. Pediatric Allergy Immunology 2022;33. [DOI: 10.1111/pai.13836] [Reference Citation Analysis]
121 Al-shami SJ, Department of Dermatology, ”Elias” University Emergency Hospital, Bucharest, Romania, Sandru F, Dumitrascu MC, Popa A, Department of Dermatology, ”Elias” University Emergency Hospital, Bucharest, Romania, ”Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, Department of Dermatology, ”Elias” University Emergency Hospital, Bucharest, Romania. The intestinal microbiome and the role of probiotics/prebiotics in the therapeutic approach of atopic dermatitis: A review. RJMM 2022;125:480-486. [DOI: 10.55453/rjmm.2022.125.3.19] [Reference Citation Analysis]
122 Patruno C, Potestio L, Napolitano M. Clinical phenotypes of adult atopic dermatitis and related therapies. Current Opinion in Allergy & Clinical Immunology 2022;22:242-249. [DOI: 10.1097/aci.0000000000000837] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
123 Ridd MJ, Santer M, Macneill SJ, Sanderson E, Wells S, Webb D, Banks J, Sutton E, Roberts A, Liddiard L, Wilkins Z, Clayton J, Garfield K, Barrett TJ, Lane JA, Baxter H, Howells L, Taylor J, Hay AD, Williams HC, Thomas KS. Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, phase 4, superiority trial. The Lancet Child & Adolescent Health 2022;6:522-532. [DOI: 10.1016/s2352-4642(22)00146-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Banzon TM, Kelly MS, Bartnikas LM, Sheehan WJ, Cunningham A, Harb H, Crestani E, Valeri L, Greco KF, Chatila TA, Phipatanakul W, Lai PS. Atopic Dermatitis Mediates the Association Between an IL4RA Variant and Food Allergy in School-Aged Children. J Allergy Clin Immunol Pract 2022;10:2117-2124.e4. [PMID: 35589010 DOI: 10.1016/j.jaip.2022.04.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
125 Zhang Y, Du W, Zhu D, Li M, Qu L, Rao G, Lin Y, Tong X, Sun Y, Huang F. Vasicine alleviates 2,4-dinitrochlorobenzene-induced atopic dermatitis and passive cutaneous anaphylaxis in BALB/c mice. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109102] [Reference Citation Analysis]
126 Ali K, Wu L, Qiu Y, Li M. Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab. Front Med 2022;9. [DOI: 10.3389/fmed.2022.932766] [Reference Citation Analysis]
127 Bernerd F, Passeron T, Castiel I, Marionnet C. The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity. Int J Mol Sci 2022;23:8243. [PMID: 35897826 DOI: 10.3390/ijms23158243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
128 Vanessa VV, Wan Ahmad Kammal WSL, Lai ZW, How KN. A Review of Moisturizing Additives for Atopic Dermatitis. Cosmetics 2022;9:75. [DOI: 10.3390/cosmetics9040075] [Reference Citation Analysis]
129 Schild M, Weber V, Thaçi D, Kisser A, Galetzka W, Enders D, Zügel F, Ohlmeier C, Gothe H. Treatment Patterns and Healthcare Resource Utilization Among Patients with Atopic Dermatitis: A Retrospective Cohort Study Using German Health Claims Data. Dermatol Ther (Heidelb). [DOI: 10.1007/s13555-022-00773-3] [Reference Citation Analysis]
130 Su W, Zhang J, Yang S, Tang M, Shen Y, Liu C, Ji J, Maurer M, Jiao Q. Galectin-9 contributes to the pathogenesis of atopic dermatitis via T cell immunoglobulin mucin-3. Front Immunol 2022;13:952338. [DOI: 10.3389/fimmu.2022.952338] [Reference Citation Analysis]
131 Xiong H, Yang J, Liu T, Liu G, Han Y, Dong X, Zuo D. Stem Cells from Human Exfoliated Deciduous Teeth Attenuate Atopic Dermatitis Symptoms in Mice through Modulating Immune Balance and Skin Barrier Function. Mediators of Inflammation 2022;2022:1-11. [DOI: 10.1155/2022/6206883] [Reference Citation Analysis]
132 Papapostolou N, Xepapadaki P, Gregoriou S, Makris M. Atopic Dermatitis and Food Allergy: A Complex Interplay What We Know and What We Would Like to Learn. JCM 2022;11:4232. [DOI: 10.3390/jcm11144232] [Reference Citation Analysis]
133 Galiniak S, Rachel M. Fractional Exhaled Nitric Oxide in Teenagers and Adults with Atopic Dermatitis. Advances in Respiratory Medicine 2022;90:237-245. [DOI: 10.3390/arm90040033] [Reference Citation Analysis]
134 Fu H, Li Y, Huang H, Wang D, Lou X. Serum Vitamin D Level and Efficacy of Vitamin D Supplementation in Children with Atopic Dermatitis: A Systematic Review and Meta-analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/9407888] [Reference Citation Analysis]
135 Ogawa T, Ishitsuka Y. The Role of KEAP1-NRF2 System in Atopic Dermatitis and Psoriasis. Antioxidants 2022;11:1397. [DOI: 10.3390/antiox11071397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
136 Fagundes BO, de-Sousa TR, Victor JR. Gamma-delta (γδ) T cell-derived cytokines (IL-4, IL-17, IFN-γ and IL-10) and their possible implications for atopic dermatitis development. Int J Dermatol 2022. [PMID: 35844012 DOI: 10.1111/ijd.16364] [Reference Citation Analysis]
137 Hollstein MM, Matzke SS, Lorbeer L, Forkel S, Fuchs T, Lex C, Buhl T. Intracutaneous Skin Tests and Serum IgE Levels Cannot Predict the Grade of Anaphylaxis in Patients with Insect Venom Allergies. J Asthma Allergy 2022;15:907-18. [PMID: 35836970 DOI: 10.2147/JAA.S367272] [Reference Citation Analysis]
138 Li C, Lu Y, Han X. Identification of Effective Diagnostic Biomarkers and Immune Cell Infiltration in Atopic Dermatitis by Comprehensive Bioinformatics Analysis. Front Mol Biosci 2022;9:917077. [DOI: 10.3389/fmolb.2022.917077] [Reference Citation Analysis]
139 Pan Y, Du D, Wang L, Wang X, He G, Jiang X. The Role of T Helper 22 Cells in Dermatological Disorders. Front Immunol 2022;13:911546. [DOI: 10.3389/fimmu.2022.911546] [Reference Citation Analysis]
140 Fang Z, Pan T, Wang H, Zhu J, Zhang H, Zhao J, Chen W, Lu W. Limosilactobacillus reuteri Attenuates Atopic Dermatitis via Changes in Gut Bacteria and Indole Derivatives from Tryptophan Metabolism. IJMS 2022;23:7735. [DOI: 10.3390/ijms23147735] [Reference Citation Analysis]
141 Ma X, Ru Y, Luo Y, Kuai L, Chen Q, Bai Y, Liu Y, Chen J, Luo Y, Song J, Zhou M, Li B. Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical Relevance. Front Cell Dev Biol 2022;10:942838. [DOI: 10.3389/fcell.2022.942838] [Reference Citation Analysis]
142 Cho YS, Kim HO, Woo SM, Lee DH. Use of Dexpanthenol for Atopic Dermatitis—Benefits and Recommendations Based on Current Evidence. JCM 2022;11:3943. [DOI: 10.3390/jcm11143943] [Reference Citation Analysis]
143 Song MH, Gupta A, Sasidharan Nair V, Oh K. CD4+ T cells play an essential role in chronic MC903-induced skin inflammation. Biochemical and Biophysical Research Communications 2022;612:8-14. [DOI: 10.1016/j.bbrc.2022.04.106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Liu W, Song W, Luo Y, Dan H, Li L, Zhang Z, Zhou D, You P. Angelica Yinzi alleviates 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the MAPKs/NF-kB signaling pathway. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.07.003] [Reference Citation Analysis]
145 Serra-baldrich E, Santamaría-babí L, Francisco Silvestre J. Nemolizumab: un innovador tratamiento biológico para el control de la interleuquina 31 (IL-31) clave en la dermatitis atópica y el prurigo nodular. Actas Dermo-Sifiliográficas 2022;113:674-684. [DOI: 10.1016/j.ad.2021.12.014] [Reference Citation Analysis]
146 Alakeel A, Al Sheikh A, Alraddadi AA, Alattas KM, Aldayel M, Alajlan MA, Al-haddab M, Almohideb M, Fatani M, Hamadah IR, Alharithy R, Binamer Y, Papp K, Elaraby A. Management of Atopic Dermatitis in Adults in Saudi Arabia: Consensus Recommendations from the Dermatological Expert Group. CCID 2022;Volume 15:1435-45. [DOI: 10.2147/ccid.s357178] [Reference Citation Analysis]
147 Serra-baldrich E, Santamaria-babí L, Francisco Silvestre J. [Translated article] Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis. Actas Dermo-Sifiliográficas 2022;113:T674-T684. [DOI: 10.1016/j.ad.2022.06.001] [Reference Citation Analysis]
148 Mohn CH, Blix HS, Brænd AM, Nafstad P, Nygard S, Halvorsen JA. Treatment Patterns of Atopic Dermatitis Medication in 0-10-Year-Olds: A Nationwide Prescription-Based Study. Dermatol Ther (Heidelb) 2022. [PMID: 35764870 DOI: 10.1007/s13555-022-00754-6] [Reference Citation Analysis]
149 Frølunde AS, Vestergaard C, Deleuran M. Skin Barrier Abnormalities in Atopic Dermatitis. Curr Treat Options Allergy. [DOI: 10.1007/s40521-022-00310-9] [Reference Citation Analysis]
150 Goh MS, Yun JS, Su JC. Management of atopic dermatitis: a narrative review. Med J Aust 2022;216:587-93. [PMID: 35644531 DOI: 10.5694/mja2.51560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Cantarutti A, Amidei CB, Bonaugurio AS, Rescigno P, Canova C. Early-life exposure to antibiotics and subsequent development of atopic dermatitis. Expert Rev Clin Pharmacol 2022. [PMID: 35723891 DOI: 10.1080/17512433.2022.2092471] [Reference Citation Analysis]
152 Song H, Park SH, Kim HJ, Jang S, Kim T. Spatholobus suberectus Dunn Water Extract Ameliorates Atopic Dermatitis–Like Symptoms by Suppressing Proinflammatory Chemokine Production In Vivo and In Vitro. Front Pharmacol 2022;13:919230. [DOI: 10.3389/fphar.2022.919230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Labib A, Ju T, Yosipovitch G. Managing Atopic Dermatitis with Lebrikizumab - The Evidence to Date. Clin Cosmet Investig Dermatol 2022;15:1065-72. [PMID: 35702658 DOI: 10.2147/CCID.S295672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Feng S, Liu W, Deng S, Song G, Zhou J, Zheng Z, Song Z. An Atopic Dermatitis-Like Mouse Model by Alternate Epicutaneous Application of Dinitrofluorobenzene and an Extract of Dermatophagoides Farinae. Front Med 2022;9:843230. [DOI: 10.3389/fmed.2022.843230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Chen H, Zhuo C, Zheng L. Assessing Causal Associations of Atopic Dermatitis With Heart Failure and Other Cardiovascular Outcomes: A Mendelian Randomization Study. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.868850] [Reference Citation Analysis]
156 Galli E, Fortina AB, Ricci G, Maiello N, Neri I, Baldo E, Berti I, Bonamonte D, Capra L, Carboni E, Carello R, Caroppo F, Cavagni G, Chinellato I, Cipriani F, Comberiati P, Diociaiuti A, Di Lernia V, Duse M, Filippeschi C, Giannetti A, Giovannini M, Licari A, Marseglia GL, Pace M, Patrizi A, Pajno GB, Peroni D, Villani A, Eichenfield L. Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP). Ital J Pediatr 2022;48:95. [PMID: 35701810 DOI: 10.1186/s13052-022-01278-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Koszorú K, Hajdu K, Brodszky V, Szabó Á, Borza J, Bodai K, Pónyai G, Szegedi A, Sárdy M, Rencz F. General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic. Dermatitis 2022. [PMID: 35674639 DOI: 10.1097/DER.0000000000000908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Li Y, Zhang B, Guo J, Cao Z, Shen M. The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis. J Dermatolog Treat 2022;:1-10. [PMID: 35670101 DOI: 10.1080/09546634.2022.2080170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Asano K, Tamari M, Zuberbier T, Yasudo H, Morita H, Fujieda S, Nakamura Y, Traidl S, Hamelmann E, Raap U, Babina M, Nagase H, Okano M, Katoh N, Ebisawa M, Renz H, Izuhara K, Worm M. Diversities of allergic pathologies and their modifiers: Report from the second DGAKI-JSA meeting. Allergol Int 2022:S1323-8930(22)00044-2. [PMID: 35662539 DOI: 10.1016/j.alit.2022.05.003] [Reference Citation Analysis]
160 Liu Y, Du X, Zhai S, Tang X, Liu C, Li W. Gut microbiota and atopic dermatitis in children: a scoping review. BMC Pediatr 2022;22:323. [PMID: 35655175 DOI: 10.1186/s12887-022-03390-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Hawerkamp HC, Fahy CMR, Fallon PG, Schwartz C. Break on through: The role of innate immunity and barrier defence in atopic dermatitis and psoriasis. Skin Health Dis 2022;2:e99. [PMID: 35677926 DOI: 10.1002/ski2.99] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
162 Schick F, Lechner J, Notter F. Linking Dentistry and Chronic Inflammatory Autoimmune Diseases – Can Oral and Jawbone Stressors Affect Systemic Symptoms of Atopic Dermatitis? A Case Report. IMCRJ 2022;Volume 15:323-338. [DOI: 10.2147/imcrj.s367434] [Reference Citation Analysis]
163 Qinwufeng G, Jiacheng L, Xiaoling L, Tingru C, Yunyang W, Yanlong Y. Jiu-Wei-Yong-An Formula suppresses JAK1/STAT3 and MAPK signaling alleviates atopic dermatitis-like skin lesions. J Ethnopharmacol 2022;:115428. [PMID: 35659915 DOI: 10.1016/j.jep.2022.115428] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
164 Hu T, Todberg T, Andersen D, Danneskiold-Samsøe NB, Hansen SBN, Kristiansen K, Ewald DA, Brix S, Rosa JCD, Hoof I, Skov L, Litman T. Profiling the Atopic Dermatitis Epidermal Transcriptome by Tape Stripping and BRB-seq. Int J Mol Sci 2022;23:6140. [PMID: 35682818 DOI: 10.3390/ijms23116140] [Reference Citation Analysis]
165 Rossi CM, Lenti MV, Merli S, Licari A, Votto M, Marseglia GL, Di Sabatino A. Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications. Clin Transl Allergy 2022;12:e12146. [PMID: 35620572 DOI: 10.1002/clt2.12146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
166 Zhang Y, Heinemann N, Rademacher F, Darvin ME, Raab C, Keck CM, Vollert H, Fluhr JW, Gläser R, Harder J, Meinke MC. Skin Care Product Rich in Antioxidants and Anti-Inflammatory Natural Compounds Reduces Itching and Inflammation in the Skin of Atopic Dermatitis Patients. Antioxidants 2022;11:1071. [DOI: 10.3390/antiox11061071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Nicolaou N, Pancheva R, Karaglani E, Sekkidou M, Marinova-achkar M, Popova S, Tzaki M, Kapetanaki A, Iacovidou N, Boutsikou T, Iliodromiti Z, Papaevangelou V, Sardeli O, Xepapadaki P, Papathoma E, Thijs-verhoeven I, Kudla U, Ulfman LH, Schaafsma A, Manios Y. The Risk Reduction Effect of a Nutritional Intervention With a Partially Hydrolyzed Whey-Based Formula on Cow's Milk Protein Allergy and Atopic Dermatitis in High-Risk Infants Within the First 6 Months of Life: The Allergy Reduction Trial (A.R.T.), a Multicenter Double-Blinded Randomized Controlled Study. Front Nutr 2022;9:863599. [DOI: 10.3389/fnut.2022.863599] [Reference Citation Analysis]
168 Tominaga M, Takamori K. Peripheral itch sensitization in atopic dermatitis. Allergol Int 2022:S1323-8930(22)00041-7. [PMID: 35624035 DOI: 10.1016/j.alit.2022.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
169 Lee KP, Plante J, Korte JE, Elston DM. Oral Janus kinase inhibitors in the treatment of atopic dermatitis: A systematic review and meta‐analysis. Skin Health and Disease 2022. [DOI: 10.1002/ski2.133] [Reference Citation Analysis]
170 Chen W, Li Y, Steinhoff M, Zhang W, Buddenkotte J, Buhl T, Zhu R, Yan X, Lu Z, Xiao S, Wang J, Meng J. The PLAUR signaling promotes chronic pruritus. FASEB J 2022;36:e22368. [PMID: 35596683 DOI: 10.1096/fj.202200079R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
171 Bagel J, Nguyen TQ, Lima H, Jain N, Pariser DM, Hsu S, Yosipovitch G, Zhang H, Chao J, Bansal S, Chen Z, Richman D, Korotzer A, Ardeleanu M. Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE). Dermatol Ther (Heidelb) 2022. [PMID: 35590038 DOI: 10.1007/s13555-022-00742-w] [Reference Citation Analysis]
172 Fölster-Holst R. Die Rolle des Hautmikrobioms bei atopischer Dermatitis - Zusammenhänge und Konsequenzen. J Dtsch Dermatol Ges 2022;20:571-8. [PMID: 35578413 DOI: 10.1111/ddg.14709_g] [Reference Citation Analysis]
173 Buhl T. Bei der atopischen Dermatitis hängt alles mit allem zusammen. J Dtsch Dermatol Ges 2022;20:565-6. [PMID: 35578422 DOI: 10.1111/ddg.14815_g] [Reference Citation Analysis]
174 Buhl T. Everything is connected in atopic dermatitis. J Dtsch Dermatol Ges 2022;20:565-6. [PMID: 35578414 DOI: 10.1111/ddg.14815] [Reference Citation Analysis]
175 Shen C, Shen B, Zhu J, Yuan H, Hu J. Topical delivery of pluronic F127/TPGS mixed micelles-based hydrogel loaded with glycyrrhizic acid for atopic dermatitis treatment. Drug Dev Ind Pharm 2022;:1-18. [PMID: 35579672 DOI: 10.1080/03639045.2022.2077957] [Reference Citation Analysis]
176 Wang Y, Hou J, Tsui JC, Wang L, Zhou J, Chan UK, Lo CJY, Siu PLK, Loo SKF, Tsui SKW. Unique gut microbiome signatures among adult patients with moderate to severe atopic dermatitis in southern Chinese.. [DOI: 10.1101/2022.05.14.491964] [Reference Citation Analysis]
177 Tsai Y, Tsai T. Overlapping Features of Psoriasis and Atopic dermatitis: From Genetics to Immunopathogenesis to Phenotypes. IJMS 2022;23:5518. [DOI: 10.3390/ijms23105518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Li Y, Shen T, Wang Q, Ma M, Tian F, She Y, Tao Y, Wang J, Chi H, Lang N, Ren J. The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial. Trials 2022;23. [DOI: 10.1186/s13063-022-06313-w] [Reference Citation Analysis]
179 Hurault G, Pan K, Mokhtari R, Olabi B, Earp E, Steele L, Williams HC, Tanaka RJ. Detecting eczema areas in digital images: an impossible task? JID Innovations 2022. [DOI: 10.1016/j.xjidi.2022.100133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Lefèvre-Utile A, Saichi M, Oláh P, Delord M, Homey B, Soumelis V; MAARS consortium. Transcriptome-based identification of novel endotypes in adult atopic dermatitis. Allergy 2022;77:1486-98. [PMID: 34689335 DOI: 10.1111/all.15150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
181 Lu Z, Xiao S, Chen W, Zhu R, Yang H, Steinhoff M, Li Y, Cheng W, Yan X, Li L, Xue S, Larkin C, Zhang W, Fan Q, Wang R, Wang J, Meng J. IL-20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis. FASEB J 2022;36:e22334. [PMID: 35486004 DOI: 10.1096/fj.202101800R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Cheng A, Wong L. Uremic Pruritus: From Diagnosis to Treatment. Diagnostics 2022;12:1108. [DOI: 10.3390/diagnostics12051108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 de Almeida Brasiel PG, Guimarães FV, Rodrigues PM, Bou-habib DC, Carvalho VDF, Behzadi P. Therapeutic Efficacy of Flavonoids in Allergies: A Systematic Review of Randomized Controlled Trials. Journal of Immunology Research 2022;2022:1-9. [DOI: 10.1155/2022/8191253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
184 Xue Y, Bao W, Zhou J, Zhao Q, Hong S, Ren J, Yang B, Wang P, Yin B, Chu C, Liu G, Jia C. Global Burden, Incidence and Disability-Adjusted Life-Years for Dermatitis: A Systematic Analysis Combined With Socioeconomic Development Status, 1990–2019. Front Cell Infect Microbiol 2022;12:861053. [DOI: 10.3389/fcimb.2022.861053] [Reference Citation Analysis]
185 Ádám D, Arany J, Tóth KF, Tóth BI, Szöllősi AG, Oláh A. Opioidergic Signaling-A Neglected, Yet Potentially Important Player in Atopic Dermatitis. Int J Mol Sci 2022;23:4140. [PMID: 35456955 DOI: 10.3390/ijms23084140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Zhou W, Li A, Zhang C, Chen Y, Li Z, Lin Y. Accurate diagnosis of atopic dermatitis by applying random forest and neural networks with transcriptomic data.. [DOI: 10.1101/2022.04.04.22273382] [Reference Citation Analysis]
187 Fölster-Holst R. The role of the skin microbiome in atopic dermatitis - correlations and consequences. J Dtsch Dermatol Ges 2022. [PMID: 35384293 DOI: 10.1111/ddg.14709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
188 Zhang X, Ma H, Quaisie J, Gu C, Guo L, Liu D, Chen Y, Zhang T. Tea saponin extracted from seed pomace of Camellia oleifera Abel ameliorates DNCB-induced atopic dermatitis-like symptoms in BALB/c mice. Journal of Functional Foods 2022;91:105001. [DOI: 10.1016/j.jff.2022.105001] [Reference Citation Analysis]
189 Chong AC, Chwa WJ, Ong PY. Aeroallergens in Atopic Dermatitis and Chronic Urticaria. Curr Allergy Asthma Rep 2022. [PMID: 35362938 DOI: 10.1007/s11882-022-01033-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
190 Castillo-González R, Fernández-Delgado I, Comberiati P. Bacteriotherapy with human skin commensals in atopic dermatitis. Allergy 2022;77:1331-3. [PMID: 34713451 DOI: 10.1111/all.15162] [Reference Citation Analysis]
191 Heinz KC, Willems D, Hiligsmann M. Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective. J Med Econ 2022;:1-37. [PMID: 35350959 DOI: 10.1080/13696998.2022.2059220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Shi J, He L, Tao R, Zheng H, Li W, Huang S, Li Y, Shang S. TLR4 polymorphisms as potential predictors of atopic dermatitis in Chinese Han children. J Clin Lab Anal 2022;:e24385. [PMID: 35349724 DOI: 10.1002/jcla.24385] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Lee J, van der Valk WH, Serdy SA, Deakin C, Kim J, Le AP, Koehler KR. Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells. Nat Protoc 2022. [PMID: 35322210 DOI: 10.1038/s41596-022-00681-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
194 Zhou B, Peng C, Li L, Liu R, Zhu L, Chen X, Li J. Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study. Front Med 2022;9:838030. [DOI: 10.3389/fmed.2022.838030] [Reference Citation Analysis]
195 Jazdarehee A, Lee J, Lewis R, Mukovozov I. Potential Mechanisms of the Sparing of Atopic Dermatitis in the Diaper Region: A Scoping Review. J Cutan Med Surg 2022;:12034754221088533. [PMID: 35317630 DOI: 10.1177/12034754221088533] [Reference Citation Analysis]
196 Ndhlovu GON, Dube FS, Moonsamy RT, Mankahla A, Hlela C, Levin ME, Lunjani N, Shittu AO, Abdulgader SM. Skin and nasal colonization of coagulase-negative staphylococci are associated with atopic dermatitis among South African toddlers. PLoS ONE 2022;17:e0265326. [DOI: 10.1371/journal.pone.0265326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Wang Y, Qin D, Jin L, Liang G. Caffeoyl malic acid is a potential dual inhibitor targeting TNFα/IL-4 evaluated by a combination strategy of network analysis-deep learning-molecular simulation. Comput Biol Med 2022;145:105410. [PMID: 35325732 DOI: 10.1016/j.compbiomed.2022.105410] [Reference Citation Analysis]
198 Simpson EL, Papp KA, Blauvelt A, Chu CY, Hong HC, Katoh N, Calimlim BM, Thyssen JP, Chiou AS, Bissonnette R, Stein Gold LF, Wegzyn C, Hu X, Liu M, Liu J, Tenorio AR, Chu AD, Guttman-Yassky E. Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials. JAMA Dermatol 2022. [PMID: 35262646 DOI: 10.1001/jamadermatol.2022.0029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
199 Georgescu SR, Mitran CI, Mitran MI, Matei C, Popa GL, Erel O, Tampa M. Thiol-Disulfide Homeostasis in Skin Diseases. J Clin Med 2022;11:1507. [PMID: 35329832 DOI: 10.3390/jcm11061507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
200 Hurault G, Pan K, Mokhtari R, Olabi B, Earp E, Steele L, Williams HC, Tanaka RJ. Detecting eczema areas in digital images: an impossible task?. [DOI: 10.1101/2022.03.03.22271780] [Reference Citation Analysis]
201 Szöllősi AG, Oláh A, Lisztes E, Griger Z, Tóth BI. Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk. Front Pharmacol 2022;13:745658. [DOI: 10.3389/fphar.2022.745658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
202 Carmona-cruz S, Orozco-covarrubias L, Sáez-de-ocariz M. The Human Skin Microbiome in Selected Cutaneous Diseases. Front Cell Infect Microbiol 2022;12:834135. [DOI: 10.3389/fcimb.2022.834135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
203 Guan J, Li Y, Lu F, Feng J. Adipose-derived stem cells ameliorate atopic dermatitis by suppressing the IL-17 expression of Th17 cells in an ovalbumin-induced mouse model. Stem Cell Res Ther 2022;13:98. [PMID: 35255962 DOI: 10.1186/s13287-022-02774-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
204 Jia Q, Qiao J, Fang K, Zeng Y. Ocular Adverse Effects in Atopic Dermatitis Patients Treated With Dupilumab: A Bibliometric Analysis. Front Med 2022;9:802036. [DOI: 10.3389/fmed.2022.802036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Hurault G, Roekevisch E, Schram ME, Szegedi K, Kezic S, Middelkamp‐hup MA, Spuls PI, Tanaka RJ. Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients? Skin Health and Disease 2022;2. [DOI: 10.1002/ski2.77] [Reference Citation Analysis]
206 Wang F, Nie H, Shi C. Effects of diurnal temperature range on atopic dermatitis: Findings from a northwestern Chinese city with temperate continental climate. Urban Climate 2022;42:101133. [DOI: 10.1016/j.uclim.2022.101133] [Reference Citation Analysis]
207 Tsuchida T, Yoshida S, Takeuchi M, Kawakami K. Large-scale health insurance study showed that antibiotic use in infancy was associated with an increase in atopic dermatitis. Acta Paediatr 2022;111:607-13. [PMID: 34919283 DOI: 10.1111/apa.16221] [Reference Citation Analysis]
208 Kirsten N. Moderne Systemtherapeutika revolutionieren die Behandlung. Dtsch Dermatolog 2022;70:222-229. [DOI: 10.1007/s15011-022-4903-4] [Reference Citation Analysis]
209 Fania L, Moretta G, Antonelli F, Scala E, Abeni D, Albanesi C, Madonna S. Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets. Int J Mol Sci 2022;23:2684. [PMID: 35269828 DOI: 10.3390/ijms23052684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
210 Ricardo-Gonzalez RR, Molofsky AB, Locksley RM. ILC2s - development, divergence, dispersal. Curr Opin Immunol 2022;75:102168. [PMID: 35176675 DOI: 10.1016/j.coi.2022.102168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
211 Bonnekoh H, Butze M, Metz M. Charakterisierung der Effekte von neuen Therapien zur Behandlung der atopischen Dermatitis auf den Pruritus. J Dtsch Dermatol Ges 2022;20:150-6. [PMID: 35146882 DOI: 10.1111/ddg.14678_g] [Reference Citation Analysis]
212 Qi H, Li L, Reich A. Association of Atopic Dermatitis with Depression and Suicide: A Two-Sample Mendelian Randomization Study. BioMed Research International 2022;2022:1-7. [DOI: 10.1155/2022/4084121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
213 Ko KI, Merlet JJ, DerGarabedian BP, Zhen H, Suzuki-Horiuchi Y, Hedberg ML, Hu E, Nguyen AT, Prouty S, Alawi F, Walsh MC, Choi Y, Millar SE, Cliff A, Romero J, Garvin MR, Seykora JT, Jacobson D, Graves DT. NF-κB perturbation reveals unique immunomodulatory functions in Prx1+ fibroblasts that promote development of atopic dermatitis. Sci Transl Med 2022;14:eabj0324. [PMID: 35108061 DOI: 10.1126/scitranslmed.abj0324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Luo L, Luo Y, Xu J, Zhu R, Wu J, Liu X, Li W, Yao X. Heterogeneous origin of IgE in atopic dermatitis and psoriasis revealed by B cell receptor repertoire analysis. Allergy 2022;77:559-68. [PMID: 34738638 DOI: 10.1111/all.15173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
215 Lunjani N, Tan G, Dreher A, Sokolowska M, Groeger D, Warwyzniak M, Altunbulakli C, Westermann P, Basera W, Hobane L, Botha M, Gray C, Mankahla A, Gray C, Nadeau KC, Hlela C, Levin M, O'Mahony L, Akdis CA. Environment-dependent alterations of immune mediators in urban and rural South African children with atopic dermatitis. Allergy 2022;77:569-81. [PMID: 34086351 DOI: 10.1111/all.14974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
216 Gowthaman U, Sikder S, Lee D, Fisher C. T follicular helper cells in IgE-mediated pathologies. Current Opinion in Immunology 2022;74:133-9. [DOI: 10.1016/j.coi.2021.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
217 Rico EB, Llobet CA, Mouronte EG, García BP. Dermatosis eritematosas: eccemas. Medicine - Programa de Formación Médica Continuada Acreditado 2022;13:2781-2791. [DOI: 10.1016/j.med.2022.02.001] [Reference Citation Analysis]
218 Miyano T, Irvine AD, Tanaka RJ. Model-based meta-analysis to optimise S. aureus-targeted therapies for atopic dermatitis. JID Innovations 2022. [DOI: 10.1016/j.xjidi.2022.100110] [Reference Citation Analysis]
219 Miyano T, Irvine AD, Tanaka RJ. A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis. Allergy 2022;77:582-94. [PMID: 33894014 DOI: 10.1111/all.14870] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
220 Ketema RM, Ait Bamai Y, Miyashita C, Saito T, Kishi R, Ikeda-araki A. Phthalates mixture on allergies and oxidative stress biomarkers among children: The Hokkaido study. Environment International 2022;160:107083. [DOI: 10.1016/j.envint.2022.107083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
221 Torres T, Paiva-Lopes MJ, Gonçalo M, Claro C, Oliveira M, Gomes J, Vieira AP, Amoedo P, Alpalhão M, Nogueira M, Santiago F, Henrique M, Amaro C, Esteves T, Alves J, Cerejeira D, Mendes-Bastos P, Pestana M, Ramos L, Rocha J, Carvalho R, Teixeira L, Selores M, Mota A, Filipe P; Portuguese Group of Atopic Dermatitis. Dupilumab for atopic dermatitis: a real-world portuguese multicenter retrospective study. J Dermatolog Treat 2022;:1-12. [PMID: 35083945 DOI: 10.1080/09546634.2022.2035309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Chiricozzi A, Gori N, Maurelli M, Gisondi P, Caldarola G, De Simone C, Peris K, Girolomoni G. Biological agents targeting interleukin-13 for atopic dermatitis. Expert Opin Biol Ther 2022. [PMID: 35081849 DOI: 10.1080/14712598.2022.2035356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
223 Torres T, Gonçalo M, Paiva Lopes MJ, Claro C, Ramos L, Selores M, Mendes Bastos P, Rocha J, Carvalho R, Mota A, Filipe P. Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients. Drugs Context 2021;10:2021-9-5. [PMID: 35035495 DOI: 10.7573/dic.2021-9-5] [Reference Citation Analysis]
224 Duverdier A, Custovic A, Tanaka R. Data-driven research on eczema: systematic characterization of the field and recommendations for the future.. [DOI: 10.1101/2022.01.14.22269294] [Reference Citation Analysis]
225 Girolomoni G, Busà VM. Flare management in atopic dermatitis: from definition to treatment. Therapeutic Advances in Chronic Disease 2022;13:204062232110667. [DOI: 10.1177/20406223211066728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 Guo Y, Dou X, Jian XL, Zhang KY, Zheng YJ, Yu B. Effect of treatments on skin microbiota in patients with atopic dermatitis: a protocol for systematic review. BMJ Open 2022;12:e053488. [PMID: 34996792 DOI: 10.1136/bmjopen-2021-053488] [Reference Citation Analysis]
227 Brown SJ. Atopic eczema: How genetic studies can contribute to understanding this complex trait. J Invest Dermatol 2022:S0022-202X(21)02638-5. [PMID: 35007558 DOI: 10.1016/j.jid.2021.12.020] [Reference Citation Analysis]
228 Custurone P, Di Bartolomeo L, Guarneri F. Microorganisms in Pathogenesis and Management of Atopic Dermatitis. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-1946-6_11] [Reference Citation Analysis]
229 Koh LF, Ong RY, Common JE. Skin microbiome of atopic dermatitis. Allergol Int 2022;71:31-9. [PMID: 34838450 DOI: 10.1016/j.alit.2021.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
230 Kubanov A, Chikin V, Karamova A, Monchakovskaya E. Narrow-band medium-wave ultraviolet therapy in patients with atopic dermatitis: efficacy and safety. Vopr kurortol fizioter lech fiz kul't 2022;99:79. [DOI: 10.17116/kurort20229906179] [Reference Citation Analysis]
231 Ünlü B. Herbal medicine and common dermatologic diseases. Herbal Medicines 2022. [DOI: 10.1016/b978-0-323-90572-5.00019-6] [Reference Citation Analysis]
232 Bieber T, Feist E, Irvine AD, Harigai M, Haladyj E, Ball S, Deberdt W, Issa M, Grond S, Taylor PC. A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19. Adv Ther 2022;39:4910-60. [PMID: 36063279 DOI: 10.1007/s12325-022-02281-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
233 Rashid T, Mehraj A, Mushtaq N, Rasool S. Origin and history of immunogenetics. A Molecular Approach to Immunogenetics 2022. [DOI: 10.1016/b978-0-323-90053-9.00015-4] [Reference Citation Analysis]
234 Homey B, Ruzicka T, Wollenberg A. Atopic Dermatitis. Braun-Falco´s Dermatology 2022. [DOI: 10.1007/978-3-662-63709-8_32] [Reference Citation Analysis]
235 Ramponi G, Brunetta E, Folci M. Role of Th1 and Th2 in autoimmunity. Translational Autoimmunity 2022. [DOI: 10.1016/b978-0-12-822564-6.00020-3] [Reference Citation Analysis]
236 Silverberg JI, Simpson EL, Armstrong AW, de Bruin-Weller MS, Irvine AD, Reich K. Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis. Am J Clin Dermatol 2022;23:1-11. [PMID: 34699031 DOI: 10.1007/s40257-021-00639-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
237 Ren S, Gao Y, Wang L, Qiu C, Yang L, Li L, Xiao Y, Xiao N, Liao L, Zuo Z, Yang C, He C. Sacran polysaccharide improves atopic dermatitis through inhibiting Th2 type immune response. Life Sci 2022;288:120205. [PMID: 34871665 DOI: 10.1016/j.lfs.2021.120205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Szymańska D, Czajkowska J, Korzekwa S, Płatkowska-szczerek A. Study on the Impact of Neural Network Architecture and Region of Interest Selection on the Result of Skin Layer Segmentation in High-Frequency Ultrasound Images. Advances in Intelligent Systems and Computing 2022. [DOI: 10.1007/978-3-031-09135-3_18] [Reference Citation Analysis]
239 Nadar RM, Pathak S, Ramesh S, Govindarajulu M, Moore T, Agrawal DC, Dhanasekaran M. Cannabis-Based Cosmetic Products and Their Uses. Cannabis/Marijuana for Healthcare 2022. [DOI: 10.1007/978-981-16-8822-5_13] [Reference Citation Analysis]
240 Alharbi KS, Alenezi SK, Alnasser SM. Microbiome in Asthma. Microbiome in Inflammatory Lung Diseases 2022. [DOI: 10.1007/978-981-16-8957-4_5] [Reference Citation Analysis]
241 Bonnekoh H, Butze M, Metz M. Characterization of the effects on pruritus by novel treatments for atopic dermatitis. J Dtsch Dermatol Ges 2021. [PMID: 34958173 DOI: 10.1111/ddg.14678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
242 Karamova AE, Chikin VV, Kubanov AA, Davletbaeva LK. Long-wavelength ultraviolet A (UVA-1) phototherapy for the treatment of patients with atopic dermatitis. Vestnik dermatologii i venerologii 2021;97:26-37. [DOI: 10.25208/vdv1286] [Reference Citation Analysis]
243 Fei W, Wu J, Gao M, Wang Q, Zhao YY, Shan C, Shen Y, Chen G. Multilineage-differentiating stress-enduring cells alleviate atopic dermatitis-associated behaviors in mice. Stem Cell Res Ther 2021;12:606. [PMID: 34930455 DOI: 10.1186/s13287-021-02671-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
244 Napolitano M, Fabbrocini G, Martora F, Picone V, Morelli P, Patruno C. Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases. Cells 2021;10:3559. [PMID: 34944067 DOI: 10.3390/cells10123559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
245 Zuccolo de Bortoli SP, Chong Neto HJ, Rosário Filho NA. Different Approaches to Atopic Dermatitis by Allergists, Dermatologists, and Pediatricians. Dermatol Res Pract 2021;2021:6050091. [PMID: 34899901 DOI: 10.1155/2021/6050091] [Reference Citation Analysis]
246 Ferrucci S, Romagnuolo M, Maronese CA, Germiniasi F, Tavecchio S, Angileri L, Casazza G, Marzano AV, Genovese G. Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis. Ther Adv Chronic Dis 2021;12:20406223211058332. [PMID: 34900210 DOI: 10.1177/20406223211058332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
247 Rajagopalan M, Chitkara AJ, Dalwai S, De A, Gulati R, Mukherjee S, Mutalik S, Sharma N, Shenoi S, Vaidya P, Tilak A, Adhav C. Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus. Clin Cosmet Investig Dermatol 2021;14:1755-65. [PMID: 34848986 DOI: 10.2147/CCID.S327593] [Reference Citation Analysis]
248 Ziyab AH, Mukherjee N, Zhang H, Arshad SH, Karmaus W. Sex-specific developmental trajectories of eczema from infancy to age 26 years: A birth cohort study. Clin Exp Allergy 2021. [PMID: 34854146 DOI: 10.1111/cea.14068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
249 Mortz CG, du Toit G, Beyer K, Bindslev-Jensen C, Brockow K, Brough HA, Comberiati P, Eiwegger T, Santos A, Worm M, Ballmer-Weber BK. When and how to evaluate for immediate type food allergy in children with atopic dermatitis. Allergy 2021;76:3845-8. [PMID: 34157156 DOI: 10.1111/all.14982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
250 Amoroso M, Langgartner D, Lowry CA, Reber SO. Rapidly Growing Mycobacterium Species: The Long and Winding Road from Tuberculosis Vaccines to Potent Stress-Resilience Agents. Int J Mol Sci 2021;22:12938. [PMID: 34884743 DOI: 10.3390/ijms222312938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
251 Zhao H, Zhou J, Lu H, Xi A, Luo M, Wang K, Lv H, Wang H, Wang P, Miao J, Xu Z. Azithromycin pretreatment exacerbates atopic dermatitis in trimellitic anhydride-induced model mice accompanied by correlated changes in the gut microbiota and serum cytokines. Int Immunopharmacol 2022;102:108388. [PMID: 34819259 DOI: 10.1016/j.intimp.2021.108388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
252 Zhong Y, Qin K, Li L, Liu H, Xie Z, Zeng K. Identification of Immunological Biomarkers of Atopic Dermatitis by Integrated Analysis to Determine Molecular Targets for Diagnosis and Therapy. Int J Gen Med 2021;14:8193-209. [PMID: 34815693 DOI: 10.2147/IJGM.S331119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
253 Tao R, Li R, Wang R. Dysbiosis of skin mycobiome in atopic dermatitis. Mycoses 2021. [PMID: 34817898 DOI: 10.1111/myc.13402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
254 Kasai H, Kawasaki H, Fukushima-Nomura A, Yasuda-Sekiguchi F, Amagai M, Ebihara T, Tanese K. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure. Ann Med 2021;53:2205-14. [PMID: 34797182 DOI: 10.1080/07853890.2021.2004319] [Reference Citation Analysis]
255 Roh YS, Huang AH, Sutaria N, Choi U, Wongvibulsin S, Choi J, Bordeaux ZA, Parthasarathy V, Deng J, Patel DP, Canner JK, Grossberg AL, Kwatra SG. Real-world comorbidities of atopic dermatitis in the U.S. adult ambulatory population. J Am Acad Dermatol 2021:S0190-9622(21)02838-3. [PMID: 34800600 DOI: 10.1016/j.jaad.2021.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
256 Moniaga CS, Tominaga M, Takamori K. The Pathology of Type 2 Inflammation-Associated Itch in Atopic Dermatitis. Diagnostics (Basel) 2021;11:2090. [PMID: 34829437 DOI: 10.3390/diagnostics11112090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
257 Langer SS, Cardili RN, Melo JML, Ferriani MPL, Moreno AS, Dias MM, Bueno-Filho R, Pocente RHC, Roxo-Junior P, Silva J, Valera FCP, Coelho EB, Galvão CES, Carmona F, Aragon DC, Arruda LK. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. J Allergy Clin Immunol Pract 2021:S2213-2198(21)01250-2. [PMID: 34767999 DOI: 10.1016/j.jaip.2021.10.060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
258 Jiménez-Cortegana C, Ortiz-García G, Serrano A, Moreno-Ramírez D, Sánchez-Margalet V. Possible Role of Leptin in Atopic Dermatitis: A Literature Review. Biomolecules 2021;11:1642. [PMID: 34827640 DOI: 10.3390/biom11111642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Nagata A, Kazi T, Akter Z, Nody FA, Khan MS, Shahriar ASM, Islam MS, Nakagawa T, Inui S. The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh. Int J Environ Res Public Health 2021;18:11593. [PMID: 34770105 DOI: 10.3390/ijerph182111593] [Reference Citation Analysis]
260 Di Filippo P, Russo D, Attanasi M, Di Pillo S, Chiarelli F. Immunological Targets of Biologic Drugs in Allergic Skin Diseases in Children. Biomedicines 2021;9:1615. [PMID: 34829844 DOI: 10.3390/biomedicines9111615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
261 Outerbridge CA, Jordan TJ. Current Knowledge on Canine Atopic Dermatitis. Advances in Small Animal Care 2021;2:101-115. [DOI: 10.1016/j.yasa.2021.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Frølunde AS, Thyssen JP, Deleuran M, Vestergaard C. Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons. Am J Clin Dermatol 2021;22:775-83. [PMID: 34322849 DOI: 10.1007/s40257-021-00629-0] [Reference Citation Analysis]
263 Yun HR, Ahn SW, Seol B, Vasileva EA, Mishchenko NP, Fedoreyev SA, Stonik VA, Han J, Ko KS, Rhee BD, Seol JE, Kim HK. Echinochrome A Treatment Alleviates Atopic Dermatitis-like Skin Lesions in NC/Nga Mice via IL-4 and IL-13 Suppression. Mar Drugs 2021;19:622. [PMID: 34822493 DOI: 10.3390/md19110622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
264 Skypala I, Bauer M, DunnGalvin A, Venter C. The Challenges of Managing Multiple Food Allergies and Consequent Food Aversions. J Allergy Clin Immunol Pract 2021:S2213-2198(21)01197-1. [PMID: 34757065 DOI: 10.1016/j.jaip.2021.10.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
265 Mommert S, Schaper JT, Schaper-Gerhardt K, Gutzmer R, Werfel T. Histamine Increases Th2 Cytokine-Induced CCL18 Expression in Human M2 Macrophages. Int J Mol Sci 2021;22:11648. [PMID: 34769080 DOI: 10.3390/ijms222111648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
266 Gutermuth J, Pink AE, Worm M, Soldbro L, Bjerregård Øland C, Weidinger S. Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo-controlled, randomized, phase III clinical trial (ECZTRA 7). Br J Dermatol 2021. [PMID: 34698371 DOI: 10.1111/bjd.20832] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
267 Saeki H, Ito K, Yokota D, Tsubouchi H. Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol 2021:S0190-9622(21)02682-7. [PMID: 34710557 DOI: 10.1016/j.jaad.2021.10.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
268 Moon S, Kim DH, Shin JU. In Vitro Models Mimicking Immune Response in the Skin. Yonsei Med J 2021;62:969-80. [PMID: 34672130 DOI: 10.3349/ymj.2021.62.11.969] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
269 Matucci A, Vivarelli E, Nencini F, Maggi E, Vultaggio A. Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors. Biomedicines 2021;9:1497. [PMID: 34680614 DOI: 10.3390/biomedicines9101497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
270 Wollenberg A, Weidinger S, Worm M, Bieber T. Tralokinumab bei atopischer Dermatitis. J Dtsch Dermatol Ges 2021;19:1435-42. [PMID: 34661352 DOI: 10.1111/ddg.14545_g] [Reference Citation Analysis]
271 Chao L, Sun Y, An Z, Li J, Wu W, Liu Y, Song J. Effects of ambient temperature on outpatient visits for dermatitis in Xinxiang, China: a time-series analysis. Environ Sci Pollut Res Int 2021. [PMID: 34642884 DOI: 10.1007/s11356-021-16710-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
272 Willems A, Tapley A, Fielding A, Tng ETV, Holliday EG, van Driel ML, Ball JI, Davey AR, Patsan I, FitzGerald K, Spike NA, Magin PJ. Prevalence and Associations of General Practice Registrars' Management of Atopic Dermatitis: A Cross-Sectional Analysis from the Registrar Clinical Encounters in Training Study. Dermatol Pract Concept 2021;11:e2021128. [PMID: 34631271 DOI: 10.5826/dpc.1104a128] [Reference Citation Analysis]
273 Sum CH, Ching J, Zhang H, Loo S, Lo CW, Lai MK, Cheong PK, Yu CL, Lin ZX. Integrated Chinese and western medicine interventions for atopic dermatitis: a systematic review and meta-analysis. Chin Med 2021;16:101. [PMID: 34629103 DOI: 10.1186/s13020-021-00506-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
274 Chan LN, Magyari A, Ye M, Al-Alusi NA, Langan SM, Margolis D, McCulloch CE, Abuabara K. The epidemiology of atopic dermatitis in older adults: A population-based study in the United Kingdom. PLoS One 2021;16:e0258219. [PMID: 34614025 DOI: 10.1371/journal.pone.0258219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
275 Miyano T, Irvine AD, Tanaka RJ. Model-based meta-analysis to optimise S. aureus-targeted therapies for atopic dermatitis.. [DOI: 10.1101/2021.10.04.21264531] [Reference Citation Analysis]
276 Fölster-Holst R, Reimer R, Neumann C, Proksch E, Rodriguez E, Weidinger S, Goldust M, Hanisch E, Dähnhardt-Pfeiffer S, Freitag-Wolf S. Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis. Biology (Basel) 2021;10:1008. [PMID: 34681107 DOI: 10.3390/biology10101008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
277 Tang L, Gao J, Cao X, Chen L, Wang H, Ding H. TRPV1 mediates itch-associated scratching and skin barrier dysfunction in DNFB-induced atopic dermatitis mice. Exp Dermatol 2021. [PMID: 34608683 DOI: 10.1111/exd.14464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
278 Croce EA, Levy ML, Adamson AS, Matsui EC. Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations. J Allergy Clin Immunol 2021;148:1104-11. [PMID: 34600773 DOI: 10.1016/j.jaci.2021.09.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
279 Tauber M, Basso L. Neuro-immune interactions in allergic skin diseases. Revue Française d'Allergologie 2021;61:421-424. [DOI: 10.1016/j.reval.2021.05.001] [Reference Citation Analysis]
280 Schneider S, Li L, Zink A. The New Era of Biologics in Atopic Dermatitis: A Review. Dermatol Pract Concept 2021;11:e2021144. [PMID: 35024236 DOI: 10.5826/dpc.1104a144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
281 Liu J, Sun Y, Yuan H, Li Y, Feng J, Gao Y, Tang Y, Zhang S, Wang H, Zheng F. Mechanism of improving skin barrier function in a mouse model of atopic dermatitis using Mahuang Lianqiao Chixiaodou decoction and its disassembled formula. Journal of Traditional Chinese Medical Sciences 2021;8:309-16. [DOI: 10.1016/j.jtcms.2021.10.002] [Reference Citation Analysis]
282 Traidl S, Roesner L, Zeitvogel J, Werfel T. Eczema herpeticum in atopic dermatitis. Allergy 2021;76:3017-27. [PMID: 33844308 DOI: 10.1111/all.14853] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
283 Lim SM, Chan HC, Santosa A, Quek SC, Liu EHC, Somani J. Safety and side effect profile of Pfizer-BioNTech COVID-19 vaccination among healthcare workers: A tertiary hospital experience in Singapore. Ann Acad Med Singap 2021;50:703-11. [DOI: 10.47102/annals-acadmedsg.2021160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
284 Traidl S, Freimooser S, Werfel T. Janus kinase inhibitors for the therapy of atopic dermatitis. Allergol Select 2021;5:293-304. [PMID: 34532638 DOI: 10.5414/ALX02272E] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
285 Sitko K, Bednarek M, Mantej J, Trzeciak M, Tukaj S. Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis. Cell Stress Chaperones 2021;26:1001-7. [PMID: 34532820 DOI: 10.1007/s12192-021-01238-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
286 Stölzl D, Weidinger S, Drerup K. A new era has begun: Treatment of atopic dermatitis with biologics. Allergol Select 2021;5:265-73. [PMID: 34532635 DOI: 10.5414/ALX02259E] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
287 Kim J, Kwon SK, Lee IS, Yeom M, Hahm DH, Park HJ, Kim K. Effect of Acupuncture on Gut-Brain Axis Parameters in Patients with Atopic Dermatitis: A Study Protocol for a Randomized, Participant- and Assessor-Blind, Sham-Controlled Trial. Evid Based Complement Alternat Med 2021;2021:5584247. [PMID: 34527063 DOI: 10.1155/2021/5584247] [Reference Citation Analysis]
288 Staudacher O, Krüger R, Kölsch U, Thee S, Gratopp A, Wahn V, Lau S, von Bernuth H. Relieving job: Dupilumab in autosomal dominant STAT3 hyper-IgE syndrome. J Allergy Clin Immunol Pract 2021:S2213-2198(21)01001-1. [PMID: 34536614 DOI: 10.1016/j.jaip.2021.08.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
289 Kiiski V, Salava A, Susitaival P, Barnhill S, Remitz A, Heliovaara M. Atopic dermatitis in adults: a population-based study in Finland. Int J Dermatol 2021. [PMID: 34510428 DOI: 10.1111/ijd.15912] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
290 Giua C, Floris NP, Schlich M, Keber E, Gelmetti C. Dermatitis in community pharmacies: a survey on italian pharmacists’ management and implications on corticophobia. PHAR 2021;68:671-7. [DOI: 10.3897/pharmacia.68.e70452] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
291 Chang CJ, Wang HQ, Zhang J, Zou Y, Zhang YH, Chen JW, Chen CB, Chung WH, Ji C. Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients. Clin Cosmet Investig Dermatol 2021;14:1033-43. [PMID: 34471367 DOI: 10.2147/CCID.S325515] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
292 Wang L, Xie X, Ke B, Huang W, Jiang X, He G. Recent advances on endogenous gasotransmitters in inflammatory dermatological disorders. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.08.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
293 Sanchez J, Cherrez-Ojeda I, Galvan C, Garcia E, Hernández-Mantilla N, Londoño Garcia A, McElwee E, Rico Restrepo M, Rivas E, Hidalgo B. The Unmet Needs in Atopic Dermatitis Control in Latin America: A Multidisciplinary Expert Perspective. Dermatol Ther (Heidelb) 2021;11:1521-40. [PMID: 34449071 DOI: 10.1007/s13555-021-00595-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
294 Martin BA, Lemos CN, Dalmolin LF, Arruda C, Brait ÍSC, Cazarim MS, da Cruz-Cazarim ELC, Bueno PCP, Júnior MP, Pereira LRL, Cardili RN, Fonseca Vianna Lopez R. A New Approach to Atopic Dermatitis Control with Low-Concentration Propolis-Loaded Cold Cream. Pharmaceutics 2021;13:1346. [PMID: 34575421 DOI: 10.3390/pharmaceutics13091346] [Reference Citation Analysis]
295 Hu H, Hou X, Luo W, Li Y, Huang H, Huang X, Sun B, Zhang XD. The Molecule Sensitized Pattern of Atopic Dermatitis Patients Who Co-Sensitized to Shrimp, Cockroaches, Crab and House Dust Mites. J Asthma Allergy 2021;14:993-7. [PMID: 34408444 DOI: 10.2147/JAA.S326411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
296 Blicharz L, Rudnicka L, Czuwara J, Waśkiel-Burnat A, Goldust M, Olszewska M, Samochocki Z. The Influence of Microbiome Dysbiosis and Bacterial Biofilms on Epidermal Barrier Function in Atopic Dermatitis-An Update. Int J Mol Sci 2021;22:8403. [PMID: 34445108 DOI: 10.3390/ijms22168403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
297 Blauvelt A, Teixeira HD, Simpson EL, Costanzo A, De Bruin-Weller M, Barbarot S, Prajapati VH, Lio P, Hu X, Wu T, Liu J, Ladizinski B, Chu AD, Eyerich K. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol 2021. [PMID: 34347860 DOI: 10.1001/jamadermatol.2021.3023] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 37.0] [Reference Citation Analysis]
298 Li H, Zhang Z, Zhang H, Guo Y, Yao Z. Update on the Pathogenesis and Therapy of Atopic Dermatitis. Clin Rev Allergy Immunol 2021. [PMID: 34338977 DOI: 10.1007/s12016-021-08880-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
299 Jaworek AK, Szepietowski JC, Hałubiec P, Wojas-Pelc A, Jaworek J. Melatonin as an Antioxidant and Immunomodulator in Atopic Dermatitis-A New Look on an Old Story: A Review. Antioxidants (Basel) 2021;10:1179. [PMID: 34439427 DOI: 10.3390/antiox10081179] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
300 Fang Z, Li L, Zhang H, Zhao J, Lu W, Chen W. Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review. Front Immunol 2021;12:720393. [PMID: 34335634 DOI: 10.3389/fimmu.2021.720393] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
301 Xu YC, Wang JP, Zhu WJ, Li P. Childhood atopic dermatitis as a precursor for developing attention deficit/hyperactivity disorder. Int J Immunopathol Pharmacol 2020;34:2058738420962902. [PMID: 33045857 DOI: 10.1177/2058738420962902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
302 Zheng DX, Geller RJ, Robinson LB, Boos MD, Camargo CA Jr. A comparison of case definitions for infant atopic dermatitis in a multicenter prospective cohort study. Health Sci Rep 2021;4:e324. [PMID: 34268451 DOI: 10.1002/hsr2.324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
303 Yüksel YT, Nørreslet LB, Thyssen JP. Allergic Contact Dermatitis in Patients with Atopic Dermatitis. Curr Derm Rep 2021;10:67-76. [DOI: 10.1007/s13671-021-00335-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
304 Smith P, Yao W, Shepard S, Covington M, Lee J, Lofland J, Naim A, Sheth T, Parikh B, Yeleswaram S. Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream. Pharmaceutics 2021;13:1044. [PMID: 34371735 DOI: 10.3390/pharmaceutics13071044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
305 Yang N, Chen Z, Zhang X, Shi Y. Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis. BioDrugs 2021;35:401-15. [PMID: 34213742 DOI: 10.1007/s40259-021-00490-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
306 Streikiene L, Hofmann SC. Atopische Dermatitis. hautnah dermatologie 2021;37:42-51. [DOI: 10.1007/s15012-021-6694-9] [Reference Citation Analysis]
307 Meng J, Li Y, Fischer MJM, Steinhoff M, Chen W, Wang J. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis. Front Immunol 2021;12:696784. [PMID: 34276687 DOI: 10.3389/fimmu.2021.696784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
308 Wang SH, Zuo YG. Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases. Front Immunol 2021;12:698522. [PMID: 34249003 DOI: 10.3389/fimmu.2021.698522] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
309 Lauffer F, Biedermann T. Atopisches Ekzem: Störfeuer für eine Dreiecksbeziehung. Deutsches Ärzteblatt Online 2021. [DOI: 10.3238/persderma.2021.06.18.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
310 Lee H, Lee DH, Oh JH, Chung JH. Skullcapflavone II Suppresses TNF-α/IFN-γ-Induced TARC, MDC, and CTSS Production in HaCaT Cells. Int J Mol Sci 2021;22:6428. [PMID: 34208434 DOI: 10.3390/ijms22126428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
311 Schäbitz A, Hillig C, Farnoud A, Jargosch M, Scala E, Pilz A, Bhalla N, Mubarak M, Thomas J, Stahle M, Biedermann T, Schmidt-weber C, Theis F, Garzorz-stark N, Eyerich K K, Menden M, Eyerich S. Low numbers of cytokine transcripts drive inflammatory skin diseases by initiating amplification cascades in localized epidermal clusters.. [DOI: 10.1101/2021.06.10.447894] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
312 Hou X, Huang H, Hu H, Wang D, Sun B, Zhang XD. Short-term exposure to ambient air pollution and hospital visits for IgE-mediated allergy: A time-stratified case-crossover study in southern China from 2012 to 2019. EClinicalMedicine 2021;37:100949. [PMID: 34386741 DOI: 10.1016/j.eclinm.2021.100949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
313 Dębińska A. New Treatments for Atopic Dermatitis Targeting Skin Barrier Repair via the Regulation of FLG Expression. J Clin Med 2021;10:2506. [PMID: 34198894 DOI: 10.3390/jcm10112506] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
314 Kader HA, Azeem M, Jwayed SA, Al-Shehhi A, Tabassum A, Ayoub MA, Hetta HF, Waheed Y, Iratni R, Al-Dhaheri A, Muhammad K. Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis. Cells 2021;10:1392. [PMID: 34200009 DOI: 10.3390/cells10061392] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
315 Davari DR, Nieman EL, McShane DB, Morrell DS. Current Perspectives on the Systemic Management of Atopic Dermatitis. J Asthma Allergy 2021;14:595-607. [PMID: 34103945 DOI: 10.2147/JAA.S287638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
316 Ratchataswan T, Banzon TM, Thyssen JP, Weidinger S, Guttman-Yassky E, Phipatanakul W. Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect. J Allergy Clin Immunol Pract 2021;9:1053-65. [PMID: 33685604 DOI: 10.1016/j.jaip.2020.11.034] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
317 Yu L, Deng YH, Huang YH, Ke HJ, Guo Y, Wu JL. Comparison of Gut Microbiota Between Infants with Atopic Dermatitis and Healthy Controls in Guangzhou, China. J Asthma Allergy 2021;14:493-500. [PMID: 34007187 DOI: 10.2147/JAA.S304685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
318 Legat FJ. Itch in Atopic Dermatitis - What Is New? Front Med (Lausanne) 2021;8:644760. [PMID: 34026782 DOI: 10.3389/fmed.2021.644760] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
319 Mathyer ME, Brettmann EA, Schmidt AD, Goodwin ZA, Oh IY, Quiggle AM, Tycksen E, Ramakrishnan N, Matkovich SJ, Guttman-Yassky E, Edwards JR, de Guzman Strong C. Selective sweep for an enhancer involucrin allele identifies skin barrier adaptation out of Africa. Nat Commun 2021;12:2557. [PMID: 33963188 DOI: 10.1038/s41467-021-22821-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
320 Peng S, Chen M, Yin M, Feng H. Identifying the Potential Therapeutic Targets for Atopic Dermatitis Through the Immune Infiltration Analysis and Construction of a ceRNA Network. Clin Cosmet Investig Dermatol 2021;14:437-53. [PMID: 33994801 DOI: 10.2147/CCID.S310426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
321 Barbosa AI, Torres T, Lima SAC, Reis S. Hydrogels: A Promising Vehicle for the Topical Management of Atopic Dermatitis. Adv Therap 2021;4:2100028. [DOI: 10.1002/adtp.202100028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
322 Pereira C. Introductory Chapter: The Multispectrum Faces of Atopic Dermatitis. Atopic Dermatitis - Essential Issues 2021. [DOI: 10.5772/intechopen.95394] [Reference Citation Analysis]
323 Streikiene L, Hofmann SC. Atopische Dermatitis. CME 2021;18:9-21. [DOI: 10.1007/s11298-021-1883-8] [Reference Citation Analysis]
324 Hurault G, Delorieux V, Kim YM, Ahn K, Williams HC, Tanaka RJ. Impact of environmental factors in predicting daily severity scores of atopic dermatitis. Clin Transl Allergy 2021;11:e12019. [PMID: 33949134 DOI: 10.1002/clt2.12019] [Reference Citation Analysis]
325 Tsai HR, Lu JW, Chen LY, Chen TL. Application of Janus Kinase Inhibitors in Atopic Dermatitis: An Updated Systematic Review and Meta-Analysis of Clinical Trials. J Pers Med 2021;11:279. [PMID: 33917069 DOI: 10.3390/jpm11040279] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
326 Agache I, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong PY, O'Mahony L, Schwarze J, Warner A, Werfel T, Palomares O, Jutel M. EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy 2021;76:988-1009. [PMID: 33538044 DOI: 10.1111/all.14690] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
327 Lopez-Santamarina A, Gonzalez EG, Lamas A, Mondragon ADC, Regal P, Miranda JM. Probiotics as a Possible Strategy for the Prevention and Treatment of Allergies. A Narrative Review. Foods 2021;10:701. [PMID: 33806092 DOI: 10.3390/foods10040701] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
328 de Jesús-Gil C, Sans-de SanNicolàs L, García-Jiménez I, Ferran M, Celada A, Chiriac A, Pujol RM, Santamaria-Babí LF. The Translational Relevance of Human Circulating Memory Cutaneous Lymphocyte-Associated Antigen Positive T Cells in Inflammatory Skin Disorders. Front Immunol 2021;12:652613. [PMID: 33833765 DOI: 10.3389/fimmu.2021.652613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
329 Wu X, Zhao Y, Gu Y, Li K, Wang X, Zhang J. Interferon-Lambda 1 Inhibits Staphylococcus aureus Colonization in Human Primary Keratinocytes. Front Pharmacol 2021;12:652302. [PMID: 33828484 DOI: 10.3389/fphar.2021.652302] [Reference Citation Analysis]
330 Drozdov VN, Arefev KI, Serebrova SY, Komissarenko IA, Shikh EV, Starodubtsev AK. Efficacy and safety of antihistamines in children with atopic dermatitis. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-1-193-201] [Reference Citation Analysis]
331 Zhou J, Chen S, Song Z. Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis. Allergy Asthma Proc 2021;42:e47-54. [PMID: 33685566 DOI: 10.2500/aap.2021.42.200126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
332 Pan CX, Jee YH, Moore KJ, Kraft P, Asgari MM. Relationship between body mass index and atopic dermatitis: a Mendelian randomization approach in exploring causality: a critical appraisal. Br J Dermatol 2021;184:1045-6. [PMID: 33263183 DOI: 10.1111/bjd.19702] [Reference Citation Analysis]
333 Rindler K, Krausgruber T, Thaler FM, Alkon N, Bangert C, Kurz H, Fortelny N, Rojahn TB, Jonak C, Griss J, Bock C, Brunner PM. Spontaneously Resolved Atopic Dermatitis Shows Melanocyte and Immune Cell Activation Distinct From Healthy Control Skin. Front Immunol 2021;12:630892. [PMID: 33717163 DOI: 10.3389/fimmu.2021.630892] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
334 Nakatsuji T, Hata TR, Tong Y, Cheng JY, Shafiq F, Butcher AM, Salem SS, Brinton SL, Rudman Spergel AK, Johnson K, Jepson B, Calatroni A, David G, Ramirez-Gama M, Taylor P, Leung DYM, Gallo RL. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nat Med 2021;27:700-9. [PMID: 33619370 DOI: 10.1038/s41591-021-01256-2] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 45.0] [Reference Citation Analysis]
335 Teasdale E, Sivyer K, Muller I, Ghio D, Roberts A, Lawton S, Santer M. Children's Views and Experiences of Treatment Adherence and Parent/Child Co-Management in Eczema: A Qualitative Study. Children (Basel) 2021;8:158. [PMID: 33672514 DOI: 10.3390/children8020158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
336 Piquero-Casals J, Carrascosa JM, Morgado-Carrasco D, Narda M, Trullas C, Granger C, Fabbrocini G. The Role of Photoprotection in Optimizing the Treatment of Atopic Dermatitis. Dermatol Ther (Heidelb) 2021;11:315-25. [PMID: 33582977 DOI: 10.1007/s13555-021-00495-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
337 Miyano T, Irvine AD, Tanaka RJ. A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis.. [DOI: 10.1101/2021.02.08.21251317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
338 Vijaya Chandra SH, Srinivas R, Dawson TL Jr, Common JE. Cutaneous Malassezia: Commensal, Pathogen, or Protector? Front Cell Infect Microbiol 2020;10:614446. [PMID: 33575223 DOI: 10.3389/fcimb.2020.614446] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
339 Parekh K, Mehta TA, Dhas N, Kumar P, Popat A. Emerging Nanomedicines for the Treatment of Atopic Dermatitis. AAPS PharmSciTech 2021;22:55. [PMID: 33486609 DOI: 10.1208/s12249-021-01920-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
340 Kahremany S, Hofmann L, Harari M, Gruzman A, Cohen G. Pruritus in psoriasis and atopic dermatitis: current treatments and new perspectives. Pharmacol Rep 2021;73:443-53. [PMID: 33460006 DOI: 10.1007/s43440-020-00206-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
341 Bosma AL, Ouwerkerk W, Middelkamp-Hup MA. Children with atopic eczema experiencing increased disease severity in the pollen season more often have hay fever at a young age and a dark skin type. J Dermatol 2021;48:470-5. [PMID: 33404119 DOI: 10.1111/1346-8138.15750] [Reference Citation Analysis]
342 Köhn F. Andrologisch relevante Veränderungen am äußeren Genitale. Andrologie 2021. [DOI: 10.1007/978-3-662-61904-9_29-1] [Reference Citation Analysis]
343 Alraddadi M, Alhazmi K. The Twins-Hit Hypothesis of Atopic Dermatitis and Autoimmune Diseases. World J Environ Biosci 2021;10:24-28. [DOI: 10.51847/i74xneqidk] [Reference Citation Analysis]
344 Miyano K, Tsunemi Y. Current treatments for atopic dermatitis in Japan. J Dermatol 2021;48:140-51. [PMID: 33377547 DOI: 10.1111/1346-8138.15730] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
345 Petrova E, Hovnanian A. Advances in understanding of Netherton syndrome and therapeutic implications. Expert Opinion on Orphan Drugs 2020;8:455-87. [DOI: 10.1080/21678707.2020.1857724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
346 Jebbawi R, Fruchon S, Turrin CO, Blanzat M, Poupot R. Supramolecular and Macromolecular Matrix Nanocarriers for Drug Delivery in Inflammation-Associated Skin Diseases. Pharmaceutics 2020;12:E1224. [PMID: 33348690 DOI: 10.3390/pharmaceutics12121224] [Reference Citation Analysis]
347 Khairutdinov VR, Samtsov AV. Experience of using an emollient with an anti-inflammatory effect based on ammonium glycyrrhizinate in the complex therapy of patients with atopic dermatitis. Vestnik dermatologii i venerologii 2020;96:29-35. [DOI: 10.25208/vdv1201] [Reference Citation Analysis]
348 McAleer MA, Jakasa I, Stefanovic N, McLean WHI, Kezic S, Irvine AD. Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis. Br J Dermatol 2021;185:153-63. [PMID: 33269467 DOI: 10.1111/bjd.19703] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
349 Hurault G, Roekevisch E, Schram ME, Szegedi K, Kezic S, Middelkamp-hup MA, Spuls PI, Tanaka RJ. Can serum biomarkers predict the outcome of systemic therapy for atopic dermatitis?. [DOI: 10.1101/2020.12.02.20242404] [Reference Citation Analysis]
350 Calmels M, Guilleminault L. Prise en charge de l’allergie chez les patients asthmatiques sévères. Revue des Maladies Respiratoires Actualités 2020;12:2S423-2S433. [DOI: 10.1016/s1877-1203(20)30732-1] [Reference Citation Analysis]
351 Magnifico I, Petronio Petronio G, Venditti N, Cutuli MA, Pietrangelo L, Vergalito F, Mangano K, Zella D, Di Marco R. Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? Pharmaceuticals (Basel) 2020;13:E411. [PMID: 33266440 DOI: 10.3390/ph13110411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
352 Nezamololama N, Fieldhouse K, Metzger K, Gooderham M. Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib. Drugs Context 2020;9:2020-8-5. [PMID: 33240390 DOI: 10.7573/dic.2020-8-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
353 Kong S, Koo J, Lim SK. Associations between Stress and Physical Activity in Korean Adolescents with Atopic Dermatitis Based on the 2018-2019 Korea Youth Risk Behavior Web-Based Survey. Int J Environ Res Public Health 2020;17:E8175. [PMID: 33167427 DOI: 10.3390/ijerph17218175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
354 Misery L. Fardeau de la dermatite atopique chez l’enfant et l’adolescent. Annales de Dermatologie et de Vénéréologie 2020;147:11S31-11S36. [DOI: 10.1016/s0151-9638(20)31086-3] [Reference Citation Analysis]
355 Hurault G, Delorieux V, Kim Y, Ahn K, Williams HC, Tanaka RJ. Impact of environmental factors in predicting daily severity scores of atopic dermatitis.. [DOI: 10.1101/2020.10.27.20220947] [Reference Citation Analysis]
356 Zeng L, Liu Y, Xing C, Huang Y, Sun X, Sun G. Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation. Mediators Inflamm 2020;2020:4346367. [PMID: 33122966 DOI: 10.1155/2020/4346367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
357 Chiricozzi A, Maurelli M, Peris K, Girolomoni G. Targeting IL-4 for the Treatment of Atopic Dermatitis. Immunotargets Ther 2020;9:151-6. [PMID: 33062619 DOI: 10.2147/ITT.S260370] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]